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resumo 
 
 
A capacidade dos macrófagos alterarem o seu fenótipo entre estados pro-
inflamatórios (tipo-M1) e anti-inflamatórios (tipo-M2), faz com que a sua 
modulação seja uma estratégia promissora para mitigar a inflamação 
excessiva e/ou crónica. Os bioflavonóides são compostos naturais com 
atividade anti-inflamatória bem documentada. No entanto, pouco se sabe 
acerca dos seus efeitos metabólicos em macrófagos humanos. Nesta tese, 
utilizou-se a metabolómica baseada em RMN para averiguar de que forma 
diferentes bioflavonóides (Quercetina, Naringenina e Naringina) modulam o 
metabolismo de macrófagos humanos, com vista a compreender melhor os 
seus mecanismos de ação. Macrófagos derivados de monócitos humanos 
THP-1 foram cultivados in vitro e tratados com cada flavonóide, tanto no estado 
não-polarizado (M0) como após uma pré-polarização com LPS/IFN-γ (M1). A 
estimulação com IL-4/IL-13 (M2) foi também empregue para comparação. As 
frações polares das células foram obtidas por extração com solventes 
orgânicos e subsequentemente analisadas por espetroscopia de RMN-1H. 
Perto de 50 metabolitos intracelulares foram identificados (endometaboloma), 
sendo que a análise dos meios de cultura (exometaboloma) foi útil para estudar 
padrões de consumo e excreção. O estudo dos perfis metabólicos através de 
análise multivariada e quantitativa revelou variações consistentes perante os 
diferentes estímulos fornecidos aos macrófagos. Os três flavonóides causaram 
diferentes alterações metabólicas, sendo que o maior impacto foi observado 
para a Quercetina e o menor para a Naringina. Os principais efeitos partilhados 
por todos os flavonóides, especialmente em macrófagos pré-polarizados para 
M1, incluíram diminuição do consumo de glucose e das reservas energéticas 
(ATP, UTP, fosfocreatina). Outros efeitos foram muito específicos dependendo 
do flavonóide, nomeadamente a modulação do ciclo TCA e do metabolismo de 
aminoácidos, a resposta anti-oxidante e variações em metabolitos associados 
às membranas. De forma geral, este estudo demonstrou que, apesar de 
apresentarem capacidade semelhante de atenuar a atividade pró-inflamatória 
de macrófagos, os três flavonóides afetaram o metabolismo celular de formas 
distintas. Em estudos futuros, será importante avaliar a expressão/atividade de 
enzimas metabólicas chave, de modo a incrementar o conhecimento atual 
sobre a modulação do metabolismo de macrófagos mediada por flavonóides. 
Este conhecimento deverá pois suportar o desenvolvimento de flavonóides 
como fármacos imunomodulatórios, especialmente direcionados para a 
atenuação e/ou resolução da inflamação, por exemplo, no contexto de doenças 
associadas a inflamação crónica ou da rejeição de biomateriais implantados. 
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abstract 
 
 
The ability of macrophages to change between pro-inflammatory (M1-like) and 
anti-inflammatory (M2-like) phenotypes makes their modulation an attractive 
therapeutic strategy to mitigate excessive and/or chronic inflammation. 
Bioflavonoids are natural compounds with well documented anti-inflammatory 
activity.  However, little is known about their molecular and metabolic effects on 
human macrophages. In this thesis, NMR metabolomics has been used to 
assess how different bioflavonoids (Quercetin, Naringenin and Naringin) 
modulate the metabolism of human macrophages, with a view to better 
understand their modes of action. In vitro-cultured macrophages differentiated 
from human THP-1 monocytes were treated with each flavonoid, both in the 
uncommitted state (M0) or after pre-polarization with LPS/IFN-γ (M1). 
Treatment with IL-4/IL-13 (M2) was also carried out for comparison. Cells were 
solvent-extracted to obtain the polar fractions and subsequently analysed by 1H 
NMR spectroscopy. Near 50 intracellular metabolites were detected 
(endometabolome), whereas analysis of cells-conditioned culture medium 
(exometabolome) was useful to assess consumption and excretion patterns. 
Multivariate analysis and discrete quantitative assessments of metabolic 
profiles revealed consistent variations upon macrophage exposure to the 
different stimuli. The three flavonoids produced pronounced metabolic 
alterations, with the strongest impact being observed for Quercetin and the 
mildest for Naringin. The main effects shared by all flavonoids, especially in M1 
pre-polarized macrophages, comprised downregulation of glucose uptake and 
decreased energetic pools (ATP, UTP, phosphocreatine). Other effects were 
highly flavonoid-specific, namely TCA cycle modulation and amino acid 
metabolism, antioxidant response and variations in membrane-related 
metabolites. Overall, this work has shown that, although sharing similar ability 
to attenuate pro-inflammatory activity of macrophages, the three flavonoids 
affect macrophage metabolism in distinct ways. Future studies should entail 
assessment of key metabolic enzymes to further advance current 
understanding on flavonoid-mediated modulation of macrophage metabolism. 
This knowledge is expected to support the development of flavonoids as 
immunomodulatory drugs, especially aimed at attenuating and/or resolving 
inflammation, for instance, in the context of chronic inflammatory diseases or 
the rejection of biomaterial implants. 
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1. Introduction 
 Macrophage plasticity, polarization and metabolism 
Macrophages are specialized white blood cells with high phagocytic activity, 
which are a part of the mononuclear phagocytic system (MPS).1,2 The MPS 
consists of cells from hematopoietic origin, including tissue resident macrophages 
and circulating monocytes, which are essential for the innate immune response.2 
Most tissue resident macrophages are established during embryogenesis and 
maintained by in situ proliferation, and are present at most tissues throughout the 
body, where they can exert specific functions.3 In the context of inflammation, 
macrophages can also differentiate from circulating monocytes that are recruited 
to the inflamed site.3,4 
The main functions exerted by macrophages include maintaining tissue 
homeostasis, immune surveillance, including defence against pathogens, and 
orchestration of inflammation.2,5 In order to maintain tissue homeostasis, 
macrophages clear considerable amounts of erythrocytes in the blood every day, 
allowing for iron and haemoglobin recycling5, while also ensuring that apoptotic 
cells and cellular debris originated from tissue damage or remodelling are cleared 
from the tissue.6,7 Macrophages are also associated with pathogen detection and 
clearance through phagocytosis, proving to be an effective host defence 
mechanism for the host against harmful organisms like bacteria, fungi or viruses.8 
Indeed, tissue resident macrophages are among the first responders to tissue injury 
or an infectious pathogen. They recognize molecular patterns like PAMPs 
(pathogen-associated molecular patterns) and DAMPs (danger-associated 
molecular patterns), followed by secretion of chemical signals, like cytokines and 
chemokines, that can modulate other immune cells and contribute to the 
inflammatory response.9,10 This process is highly regulated and involves 
communication between different leukocytes.2 Tissue resident macrophages can 
also stimulate the influx of inflammatory leukocytes into the affected tissue, where 
circulating monocytes and neutrophils are the first cells to arrive.4 After infiltrating 
the tissue, monocytes differentiate into mature macrophages which contribute to 
the development and resolution of inflammation, pathogen clearance and restoring 
3 
 
 
of tissue homeostasis.4 Moreover, these macrophages are capable of interacting 
and modulating the activity of other immune cells, such as T lymphocytes.2 One of 
the mechanisms through which these white blood cells interact involves 
macrophages presenting the antigens associated with the phagocytized pathogen, 
which leads to the activation of effector T lymphocytes, bridging the innate and 
adaptive immune response.2 
 
 Canonical stimuli of macrophage polarization 
To perform such a wide variety of functions, macrophages adopt various 
polarization (or activation) states.11 Indeed, macrophages have the ability to sense 
molecular mediators and danger signals in their local microenvironment9, resulting 
in the expression of different phenotypes that consequently play different roles in 
the immune response, specifically regarding inflammation.12 In early stages of 
inflammation, macrophages display a more pro-inflammatory phenotype, being 
generally designated as M1 macrophages (classically activated).13 With time, 
macrophages tend to shift their functional phenotype towards a more anti-
inflammatory state known as M2 (alternatively activated),which help to resolve 
inflammation and regenerate the tissue.13 The M2 phenotype can be further divided 
into four subtypes (M2a, M2b, M2c and M2d), which can be obtained through 
different polarization stimuli and differ in their cytokine expression profiles (figure 
1).14 It is, however, important to mention that categorizing macrophages strictly as 
M1 or M2 is an oversimplified notion, as these phenotypes are two opposite 
extremes in a wide range of functional states.15  
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Figure 1: Differential macrophage polarization into different phenotypes upon exposure to 
various stimuli. Classical activation (M1) induced by LPS and IFN-γ (red). Alternative 
activation (blue) induced by different stimuli according to M2 subtype: M2a - IL-4 and IL-
13; M2b – Immune Complex (IC), LPS and IL-1β; M2c - IL-10; M2d – IL-6 and adenosine. 
Adapted from14,16,17. 
 
The polarization shift towards the M1 phenotype can be triggered by molecular 
patterns present in external pathogens, such as bacterial cell wall 
lipopolysaccharides (LPS) and peptidoglycans, or endogenous secretion of 
cytokines like IFN-γ by T-cells.17 LPS signal transduction is strongly associated with 
toll like receptors (TLR’s) present in macrophage membranes, with TLR4 having a 
fundamental role in its regulation.18,19 A study using mouse macrophages (RAW 
264.7 cells) showed that manipulation of either the tridimensional structure or 
expression levels of TLR4 in these cells caused significant alterations on their 
response to LPS stimulation.19 Regarding IFN-γ stimulation, it has been 
demonstrated that IFN regulatory factor (IRF1) and IFN-β play an essential part in 
the signaling pathway, with M1 markers being decreased after knockdown of IRF1 
and IFN-β in human monocyte derived macrophages (U937 monocytes).20 
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Throughout the years, several studies have been conducted to assess which 
stimuli are most effective to selectively activate macrophages in vitro into the M1 
phenotype.12,21–25 One of the most commonly used stimuli for in vitro M1 
polarization is based on the combination of LPS and IFN-γ,20 which is the stimulus 
chosen in this present work as the canonical M1 macrophage polarization. 
M2 macrophages present an additional challenge regarding stimulation and 
phenotypic characterization, given the four different subsets identified.  Briefly, the 
M2a phenotype is achieved through IL-4 and IL-13 stimulation, the M2b by immune 
complexes, TLR and IL-1R agonists, the M2c with IL-10 stimulation, and M2d 
through IL-6 and adenosines.14,16 Displaying different cytokine expression profiles, 
these subsets can have different contributions in the context of inflammation or 
tissue regeneration.14 An example of this is M2b being functionally anti-
inflammatory but retaining high levels of pro-inflammatory cytokines like IL-12, and 
M2c being the biggest contributor for IL-10 production amongst the subtypes.26 In 
this context, a study by Tang and colleagues showed that in mice with acute lung 
injury (ALI), M2c macrophages were more effective at reducing fibrosis in the lung 
when compared to M2a macrophages.26 More detailed information can be found in 
recent reviews, highlighting the differences between these subsets.14,16,17  
In vitro studies often use a combination of IL-4 and IL-13 to polarize 
macrophages towards the prototypical M2 phenotype12,17,21, this stimuli having 
been chosen for M2 polarization in the present work. Interleukins IL-4 and IL-13 
are mainly released by T-helper type 2 cells after antigen recognition, although 
many other immune cells have the ability to secrete these cytokines after specific 
stimulation.27 IL-4 binds strongly with IL-4Rα in the macrophage membrane, which 
triggers a series of signaling pathways that ultimately leads to the phenotypical 
alterations seen in M2 macrophages.28 Sharing around 25% homology with IL-4, 
IL-13 can also exert similar biochemical effects, specifically regarding the 
inflammatory and immune responses.29 
Highlighting the importance of these interleukins, a study using mice with acute 
kidney injury (AKI) showed that deletion of IL-4/IL-13 or inhibition of downstream 
components in the signaling cascade caused delayed recovery from injury and had 
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a significant increase in M1 macrophage markers with a decrease in M2 markers.30 
This corroborates the role of alternatively activated macrophages in tissue repair 
and strongly indicates that IL-4 and IL-13 are essential for driving the polarization 
towards the M2 phenotype (specifically, M2a).30 
Overall, dysregulation of this process of differential activation in macrophages 
can lead to chronic inflammation, where the affected tissue can suffer persistent 
damage and/or contribute to disease progression.31–35 This is now recognized to 
underlie a number of diseases, including cancer,31 coronary artery disease35 and 
some auto-immune diseases like rheumatoid arthritis32 and multiple sclerosis33, 
while also displaying other negative health impacts, such as the rejection of 
implanted biomaterials.34,36 Hence, multiple efforts have been conducted to further 
understand the mechanisms underlying macrophage polarization and to develop 
strategies to modulate this process.13 
 
 Phenotypic markers of macrophage polarization 
The distinction between M1 and M2 polarized macrophages can be assessed 
by the different expression of several biological molecules, including membrane 
surface receptors, cytokines and intracellular enzymes, such as iNOS or arginase-
1 (Table 1).37 By identifying/quantifying some of these molecules and associating 
them to one phenotype or the other, polarization markers may be established. It 
should be underlined, however, that such markers are dependent on the cells’ 
origin, varying significantly between murine and human macrophages.12 
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Table 1: Common polarization biomarkers (mouse and human), cytokines and 
chemokines expressed in M1 and M2 macrophages. Adapted from12,16,21,38. 
a Murine only 
 
 
1.1.2.1. Cell surface markers 
One of the most commonly used methods to characterize macrophage in vitro 
polarization is based on the analysis of expressed cell surface antigens through 
flow cytometry analysis.39 Using human macrophages derived from peripheral 
blood mononuclear cells (PBMC), Tarique and colleagues showed that 
macrophages could be separated into different populations, according to cell 
surface receptors expression.12 An increased expression of CD80 (a T-lymphocyte 
activation antigen) and CD64 (high affinity Fcγ receptor I) was strongly associated 
with human macrophage stimulation in culture with a combination of LPS and IFN-
γ.12 This increase in the CD80+CD64+ population highlighted these two surface 
receptors as good markers for identification of classical activation of 
macrophages.12 On the other hand, the expression of CD11b (ITGAM – Integrin 
Alpha M) and CD209 (DC-SIGN - Dendritic Cell-Specific Intercellular adhesion 
molecule-3-Grabbing Non-integrin) was significantly higher in macrophages 
stimulated with IL-4 and IL-13 when compared to uncommitted macrophages or 
macrophages stimulated with LPS and IFN-γ, therefore being associated with M2 
macrophages.12 
 
Cell surface markers 
Enzymes/ 
Proteins 
Cytokines Chemokines Refs 
M1 
CD64    CD68     CD80    CD86 
TLR2    TLR4     IL-1R    HLA-DR 
iNOS a 
IL-6      IL-8 
IL-12    IL-23 
TNF-α  IL-1β 
CCL2   CCL3 
CCL4   CCL5 
CCL8   CCL9 
CCL10  
CCL11 
[12] 
[16] 
[21] 
[38] 
M2 
CD36     CD163     CD206   
CD209   CD200R   IL-1R II 
Arg-1 a 
 Ym 1/2 a     
Fizz1a 
IL-10 
IL-1Rα 
TGF-β 
CCL17 
CCL22 
CCL24 
[12] 
[16] 
[21] 
[38] 
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 In another study with macrophages differentiated from THP-1 cells (human 
monocytic cell line derived from an acute monocytic leukemia patient) the M1 
phenotype was associated with CD80 and the receptor HLA-DR (Human leukocyte 
antigen – antigen D related), whereas M2 macrophages were characterized by 
increased expression of CD206 (mannose receptor) and CD163 (a hemoglobin 
scavenger receptor).21 The heterogeneity seen in surface markers used for 
macrophage phenotypic differentiation throughout literature studies can be 
associated with a lack of consensus regarding some of the methodological steps, 
such as the type, concentration or duration of the polarization stimuli used, cell 
type, culture media, etc. Additionally, even though murine macrophages are better 
characterized thus far when compared to humans, as mentioned before, 
extrapolation between polarization surface markers in murine and human 
macrophages may not be possible.12 
 
1.1.2.2. iNOS and Arginase-1 
The enzymes iNOS and arginase-1 are involved in arginine metabolism and 
can also be used as polarization markers due to their differential expression in 
activated macrophages and strong contribution to functional phenotype 
differences.40 iNOS (inducible nitric oxide synthase) is an enzyme associated with 
nitric oxide (NO) production.41 An increase in NO production caused by a higher 
iNOS expression is commonly seen in murine M1 macrophages, being associated 
with anti-microbial effects.9 There is however, a lack of consensus regarding 
whether or not human macrophages display this increase in iNOS expression after 
M1 stimulation, suggesting that iNOS is a good marker for murine models, but not 
necessarily for human macrophages.21,42 
 A similar situation occurs with arginase-1 expression, as there are 
uncertainties regarding its use as a polarization marker for alternatively activated 
(M2) human macrophages.43,44 Indeed, while some studies reported that arginase-
1 is not increased in human M2 macrophages44–46, others have shown that 
arginase-1 expression can be used as a polarization marker due to its differential 
increase in M2 macrophages when compared to M1 macrophages.47–49 This 
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discrepancy over the expression of both iNOS and arginase-1 in activated human 
macrophages has been reviewed before, where some research papers from both 
sides of the argument have been mentioned, stating that the opposing results may 
be due to several methodological disparities between studies and macrophage 
models, further contributing to the idea that standardization could be beneficial for 
overall progress in studying macrophages in the context of inflammation.42,43 
 
1.1.2.3. Cytokines and chemokines 
One of the most important phenotypic differences between M1 and M2 
macrophages and its variants, is the production and excretion of cytokines to the 
extracellular medium at the inflammation or implantation site.50 Several pro-
inflammatory cytokines are released by activated M1 macrophages, including 
various interleukins, like IL-1β, IL-6, IL-8, IL-12; tumor necrosis factors, such as 
TNF-α, and growth factors like VEGF.10 A study by Schutte and colleagues using 
THP-1 derived macrophages showed that after stimulation with LPS, macrophages 
showed a general increase in pro-inflammatory cytokines and also an increase in 
anti-wound healing cytokines, including several of those mentioned before, being 
therefore consistent with an M1 phenotype.51  
In M2 macrophage subtypes, most pro-inflammatory cytokine levels are 
decreased and anti-inflammatory cytokines like IL-1052 and TGF-β are released,53 
with the exception of M2b, which retains a high expression of pro-inflammatory 
cytokines,14 as mentioned earlier. A study conducted by Song and colleagues using 
macrophages differentiated from human PBMCs showed that after in vitro 
stimulation with IL-4, more collagen was produced by cultured fibroblasts in 
response to the increase in TGF- β secreted by macrophages.53 This mechanism 
is involved in tissue repair, which is associated with M2 macrophage subtypes.53 
IL-10 is a potent anti-inflammatory cytokine, responsible for maintaining/restoring 
homeostasis by preventing an over prolonged and consequently detrimental 
inflammatory response.13,54,55  It has been shown that impaired expression of IL-10 
can lead to more effective pathogen clearance, but it can also imply an imbalance 
in inflammation homeostasis, leading to persistent inflammation. Indeed, it is widely 
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recognized that both TGF-β and IL-10 are essential modulators of the inflammatory 
response, being involved in the resolution of inflammation and tissue repair.51,52 
Chemokines are small cytokines that also play an essential role in inflammation 
by mediating macrophage chemotaxis, stimulating immune cell migration and 
targeting inflamed tissue.56 This migration towards chemotactic agents is different 
in M1 and M2 macrophages, consequently contributing to further phenotypic 
differences between the two phenotypes.56 A study by Vogel and colleagues using 
human macrophages derived from PBMCs showed that in comparison to M1, IL-4 
stimulated M2 macrophages migrate faster and to longer distances when attracted 
by several chemokines like CCL5 and CXCL12.57 Some reviews have listed several 
differences regarding macrophages direct chemokine secretion, indicating higher 
levels of pro-inflammatory chemokines in M1 macrophages, including CCL5, 
CXCL9 and CXCL10, amongst several others.14,58 Regarding M2 macrophages, it 
has been shown that stimulation with IL-4 can up-regulate chemokines (e.g., 
CCL17, CCL22 and CCL24), which recruit immune cells involved in tissue repair 
and inflammation resolution, therefore contributing to the anti-inflammatory effect 
reported for alternatively activated macrophages.14,57,59  
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 Metabolic features of differentially activated macrophages 
It has recently come to light that macrophages at different polarization states 
require distinct metabolic programs to express their functional phenotypes and 
perform their effector functions.60–64 Activation-dependent alterations have been 
reported in several metabolic pathways, including glycolysis,65 amino acid 
metabolism (with arginine playing an essential role),66 OXPHOS and TCA cycle,67 
PPP68 and lipid metabolic pathways, including fatty acid oxidation (FAO) and fatty 
acid synthesis (FA synthesis).69 
A summarized representation of metabolism regulation in differentially activated 
macrophages is shown in Figure 2. Overall, M1 macrophages are characterized by 
increased glycolysis and pentose phosphate pathway (PPP), with a truncated TCA 
cycle and impaired OXPHOS, while M2 macrophages have been shown to display 
a normal TCA cycle and OXPHOS.62  Lipid metabolism has also been found to play 
an important role in macrophage differential activation, although some conflicting 
data exists regarding the relative importance of FA synthesis and oxidation in each 
phenotype.60–63,70,71 
Figure 2: Schematic representation of metabolic differences between M1 and M2 
macrophages. Glycolysis is increased in both phenotypes, albeit with more prevalence in 
M1, with several glycolytic enzymes and intermediates contributing to the pro-inflammatory 
phenotype. Unlike M1, which heavily rely on aerobic glycolysis, M2 macrophages display 
a normal OXPHOS and use FAO as a supplementary source of energy. PPP is 
unaltered/suppressed in M2 due to increased CARKL expression. Adapted from61,62. 
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1.1.3.1. Glycolysis and its regulation in polarized macrophages  
Glycolysis is the metabolic pathway through which glucose is transformed into 
pyruvate, with the concomitant production of NADH and ATP.63,72 Pyruvate can 
then be oxidized into acetyl-coA and enter the TCA cycle, or it can be converted 
into lactate, especially if oxygen supply is low.60 In addition to a small energetic 
yield (2 ATP molecules per each glucose molecule), glycolysis provides cells with 
several intermediate metabolites that can be used for various biosynthetic 
processes,72 including the biosynthesis of amino acid,73 lipids74 and nucleotides.75 
Similarly to tumor cells, pro-inflammatory macrophages heavily rely on 
glycolysis for energy generation, instead of OXPHOS, even when physiological 
amounts of oxygen are available.62 Considering the normoxic environment, this 
process is known as aerobic glycolysis, being commonly referred to as the Warburg 
effect.76,77 Moreover, M1 macrophages show impaired mitochondrial respiration, 
further indicating how important glycolysis is in this context.62,78  
A study by Gleeson and colleagues using human monocyte-derived 
macrophages showed that after stimulation with Mycobacterium tuberculosis, a 
significant increase in lactate was detected, reflecting an increase in glycolytic 
activity.76 Additionally, a study by Venter and colleagues using a murine 
macrophage cell line (RAW 264.7) determined that glycolysis was indispensable 
for LPS-induced macrophages’ phagocytic activity. Indeed, macrophage migration 
and phagocytosis were clearly impaired in the presence of 2-deoxyglucose (2-DG), 
a known glycolytic inhibitor.79 On the other hand, inhibiting OXPHOS with 
oligomycin, produced much less relevant alterations, which is consistent with 
glycolysis being the major source of energy in M1 macrophages.79 Both studies 
showed that pro-inflammatory stimuli (M. tuberculosis in the first study and LPS in 
the second), drive an alteration in glucose metabolism, specifically favoring 
glycolysis instead of mitochondrial respiration, even in the presence of normal 
levels of oxygen.76,79  
The role of glycolysis in M2 macrophage subtypes has been less extensively 
investigated compared to M1 macrophages. Still, some studies have reported an 
increased glycolytic rate in IL-4 or M-CSF induced macrophages, suggesting it to 
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be relevant to the functional phenotype expressed.80–82 However, M2 macrophages 
were not seen to display an impairment in OXPHOS (unlike M1) and the increase 
in glycolytic rate wasn’t as pronounced.62,83 A study conducted by Zhao and 
colleagues used murine bone marrow-derived macrophages (BMDM) polarized 
into M2 macrophages with IL-4.80 After stimulation, macrophages showed an 
increased expression in the glucose transporter GLUT-1 (consequently with a 
higher glucose uptake) and also increased levels of glycolytic enzymes.80 To further 
establish the role of glycolysis in the functional phenotype, they used 2-DG to inhibit 
glycolysis, which caused decreased expression of several murine M2 markers, 
including arginase-1, thus indicating that glycolysis is necessary for M2 phenotype 
establishment.80 Increased glycolytic rate has also been reported in human 
macrophages derived from PBMCs which were differentiated and polarized 
towards an anti-inflammatory (M2) phenotype by using M-CSF in vitro. In that 
study, inhibition of glycolysis led to impaired secretion of various cytokines, with 
macrophages not displaying their usual cytokine production patterns.82 By later 
exposing the already polarized M2 macrophages to LPS, they showed that there 
was an increase in pro-inflammatory cytokines, like IL-6.82 This was coupled with 
an additional increase in glycolysis, indicating that in response to a pathogenic 
stimuli (in this case LPS), M2 macrophages can display a slightly more pro-
inflammatory behavior, hence showing some phenotypic plasticity according to the 
microenvironment.82 Altogether, existing studies indicate that glycolysis plays a 
major role in the regulation of both M1 and M2 macrophages, with a greater impact 
on M1 macrophages due to the concomitant impairment in OXPHOS (not seen in 
M2 macrophages). 
Several enzymes from the glycolytic metabolic pathway have been implicated 
in the pro-inflammatory phenotype displayed by M1 macrophages, including 
hexokinase 1 (HK1), enolase, pyruvate kinase M2 (PKM2), amongst others.62 Both 
hexokinase 1 (HK1) and pyruvate kinase M2 (PKM2) are associated with the 
activation of the NLRP3 inflammasome, which is a multi-protein complex mainly 
responsible for the activation of inflammatory caspases and maturation of IL-1β, a 
pro-inflammatory cytokine.84–87 In murine BMDM cells, PKM2 inhibition with 
Shikonin resulted in a significant suppression of the NLRP3 inflammasome and 
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decreased secretion of IL-1β, hindering the inflammatory state.86 Additionally, a 
study by Palsson and colleagues using murine BMDM cells showed that PKM2 
could stabilize HIF-1 (hypoxia inducible factor 1), which is a known positive 
regulator for IL-1β.87 A third role for PKM2 in this context is its ability to 
phosphorylate and consequently activate STAT3, which in turn can boost the 
production of pro-inflammatory cytokines IL-6 and IL-1β.88 Enolase has also been 
implicated in an increased inflammatory state, specifically regarding synovial 
inflammation in rheumatoid arthritis, with pro-inflammatory cytokines TNF-α and IL-
1α/β levels being particularly affected.89 In a study using THP-1 cells, the enzyme 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) has been proposed as an 
important mediator between glycolysis and inflammation, since GAPDH can 
interact with TNF-α mRNA, suppressing TNF-α levels post-transcriptionally.90 
However, when GAPDH is engaged in the glycolytic pathway, its availability for 
TNF-α mRNA suppression is lower, which results in higher levels of TNF-α, 
therefore contributing to a more pro-inflammatory state.91 
In terms of regulatory mechanisms, some signaling pathways have been 
referred to be involved in glycolysis upregulation during macrophage activation. In 
human monocytic cells, specifically THP-1 (cell line) and PBMC (isolated from 
blood from healthy volunteers), it has been shown that LPS can induce 
phosphorylation (activation) of the Ser and Thr kinase (AKT) through the 
phosphatidylinositol 3-kinase (PI3K)-AKT signaling pathway, triggered by TLR-4 
receptor stimulation.91 One of the ways through which AKT (or protein kinase B- 
PKB) regulates glucose metabolism is by promoting the translocation of glucose 
transporters to the surface membrane, increasing glucose cell uptake, thus feeding 
more substrate to the glycolytic pathway.92 In regard to macrophage stimulation 
with IL-4 (to induce M2-like phenotype), PI3K-AKT has also been found activated, 
impacting on glucose metabolism.93 A study by Covarrubias and colleagues using 
BMDM cells showed that AKT inhibition resulted in a diminished increase in 
glucose uptake by IL-4 stimulated macrophages when compared to macrophages 
without AKT inhibition.94 Additionally, by inhibiting glycolysis with 2-DG, they 
showed a reduced expression of M2 associated genes, which means that AKT is 
not only contributing to increased glucose uptake and metabolism, but also to the 
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enhanced expression of M2 associated genes.94 Another major role of AKT 
signaling regards its interaction with mTOR (mechanistic target for rapamycin), 
which is key to the regulation of macrophage polarization.93 After activation, AKT 
can phosphorylate the TSC (tuberous sclerosis complex), inactivating it. 
Considering how this complex is responsible for negatively regulating mTORC1 
(complex 1), AKT leads to mTORC1 activation, which is responsible for increased 
gene expression linked to the promotion of cell growth and metabolism, regulating 
various metabolic processes, including glycolysis.94,95 Further establishing the role 
of mTOR in glycolytic metabolism regulation, a specific mTOR signaling pathway 
involving mTORC2 (complex 2) has been implicated in regulating IRF-4 (interferon 
regulatory factor 4), which is a transcriptional factor responsible for the expression 
of several genes, including those encoding glycolytic enzymes.95  A study by Huang 
and colleagues using IL-4 polarized BMDM cells showed that M2 macrophages 
with an IRF-4 deficiency displayed an impaired glycolytic rate, subsequent to a 
significantly decreased expression in glycolytic enzymes.95  
It may therefore be concluded that glycolysis plays an important role in 
macrophage activation, both in M1 and M2 phenotypes (albeit with differences 
regarding its predominance as the cells’ main energy provider), and that AKT is a 
major regulator of glucose metabolism in activated macrophages.94 Notably, 
enhanced glycolysis cannot be considered a mere consequence of macrophage 
activation, but rather as an essential regulating process that is necessary for 
optimal expression of several genes that contribute to the phenotypical expression 
in activated macrophages. 
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1.1.3.2. PPP and oxidative/nitrosative stress in polarized macrophages  
The PPP is a metabolic pathway that works in parallel with glycolysis, 
contributing to the maintenance of the cellular redox balance through NADPH 
production, and to the promotion of cell proliferation and growth through nucleotide 
biosynthesis.75 An increase in this metabolic route has been associated with M1 
macrophages, but not with M2 subtypes, indicating its role in macrophage pro-
inflammatory activity.68 
One of the major links between PPP and the inflammatory response is through 
the production of reactive oxygen species (ROS) and reactive nitrogen species 
(RNS), associated with oxidative and nitrosative stress promotion, respectively.96 
Reactive species such as nitric oxide (NO) and hydrogen peroxide (H2O2) possess 
anti-microbial effects,97 thereby aiding macrophage mediated pathogen 
clearance.97 In M1 macrophages, it has been shown that increased NADPH 
production through the PPP is responsible for increased production of ROS and 
stimulation of gene expression, including enzymes like iNOS and NADP oxidase 
(NOX), therefore contributing for NO production and enhancing the anti-microbial 
response.96 Indeed, LPS stimulation of RAW 264.7 murine macrophages with 
G6PD repression (Glucose-6-phosphate dehydrogenase - the first enzyme of PPP) 
caused a significant decrease in pro-inflammatory cytokines and in the levels of 
both ROS and RNS, hindering the macrophages’ pro-inflammatory activity.96 On 
the other hand, NADPH is also involved in the formation of glutathione (GSH), a 
tripeptide with strong antioxidant effect by scavenging ROS and therefore lowering 
the cellular oxidative stress, possibly working as a countermeasure to prevent the 
inflammatory response from being overly dominant or prolonged.68,96  
The enzyme carbohydrate kinase-like protein (CARKL), a sedoheptulose 
kinase responsible for converting sedoheptulose into sedoheptulose-7-phosphate 
(S7P), has been identified as a key control point which limits the flux through the 
PPP.68 A decrease in CARKL expression was observed both in vitro and in vivo in 
human and murine LPS-stimulated macrophages.68 In M1 polarized RAW 264.7 
macrophages, decreased CARKL expression was correlated to enhanced M1 
activation, specifically regarding GSH and NADH production.68 In contrast, IL-4 
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stimulated macrophages (M2) showed an upregulation in CARKL, and no 
stimulation of the PPP pathway.68 
Despite the PPP not being upregulated in IL-4 stimulated macrophages (M2), 
it has been shown that ROS are still necessary for M2 polarization.96,98 Blocking 
ROS production in BMDM cells with BHA (butylated hydroxyanisol) resulted in a 
decreased expression of several M2 polarization markers after stimulation with M-
CSF, indicating that ROS unavailability can actually hamper monocyte 
differentiation to macrophages, specifically regarding M2 macrophages.98 
Interestingly though, ROS inhibition showed no significant impairment in monocyte 
differentiation and polarization towards M1 macrophages (in this case, BMDM cells 
with GM-CSF).98 
 
1.1.3.3. TCA cycle in polarized macrophages 
One of the major metabolic differences between differentially activated 
macrophages regards mitochondrial OXPHOS regulation.99 While M1 
macrophages present an impairment in OXPHOS, M2 macrophages use it as their 
main source of ATP, supplying the cell with the necessary energy for carrying out 
various biological functions.99 In M1 macrophages, OXPHOS impairment is 
associated with tricarboxylic acid (TCA) cycle dysfunction, as shown in Figure 
3.100,101 A first breaking point has been found in the conversion step of isocitrate to 
α-ketoglutarate, catalyzed by the enzyme isocitrate dehydrogenase (IDH), whereas 
a second break involves the conversion of succinate to fumarate by succinate 
dehydrogenase (SDH).102 These breaks will consequently result in the 
accumulation of upstream metabolites, namely citrate and isocitrate (resulting from 
the first break), together with succinate (second break), which are essential for M1 
phenotype establishment.102 
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Figure 3: Schematic representation of the altered TCA cycle in M1 macrophages. The first 
breakpoint in IDH is responsible for citrate, isocitrate and aconitate accumulation. The latter 
can be further converted to itaconate, which is then involved in the competitive inhibition 
of SDH and has anti-microbial effects. Succinate accumulation can stabilize HIF-1 and 
subsequently increase IL-1β levels. The metabolites downstream of the breaks are 
replenished through anaplerotic pathways, like glutaminolysis or the aspartate-
argininosuccinate shunt (AASS). Adapted from61. 
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1.1.3.3.1. Succinate metabolism in M1 macrophages 
Succinate has been shown to importantly account for the pro-inflammatory 
phenotype of classically activated (M1) macrophages.99 In particular, succinate-
mediated changes include regulating mechanisms involving transcriptional factors 
like HIF-1, mitochondrial ROS production, and alterations in amino acid 
metabolism, specifically regarding glutamine and arginine.99 Succinate 
accumulation in the mitochondria of activated inflammatory macrophages is linked 
with the activation of the transcriptional factor HIF-1 (hypoxia inducible factor), 
independent of oxygen availability.99 HIF-1 is composed of two subunits (α and β), 
whereby the α subunit binds to molecular oxygen and the β subunit interacts with 
DNA sequences, activating gene transcription involved in several cellular 
processes like cell proliferation, inflammation and metabolism.103 It has been 
shown that SDH inhibition and subsequent succinate accumulation results in 
inhibition of prolyl hydroxylases (PHD), which are responsible for preventing HIF-1 
stabilization.104 When PHD are active and oxygen is available at physiological 
levels, HIF-1 is hydroxylated, allowing the association of the VHL (von hippel-
lindau) factor, which serves as a signal for proteasomal degradation through the 
ubiquitin-proteasome complex.105 Besides succinate, other TCA cycle 
intermediates like fumarate seem to be involved in HIF-1 stabilization through PHD 
inhibition.106 HIF-1 has been associated with several roles in the immune response, 
including regulating inflammatory cytokine expression, NO synthesis, 
prostaglandins, amongst others.107 An example of cytokine regulation regards IL-
1β production in M1 macrophages (BMDM stimulated with LPS), as it has been 
found that IL-1β levels were significantly decreased in cells where the HIF-1 
pathway was somehow disrupted.99 Contrarily, macrophages with high succinate 
levels (and, hence, HIF-1 stabilization) displayed a notorious increase in IL-1β 
production, contributing to the pro-inflammatory phenotype.99 Out of many proteins 
that are differently expressed due to HIF-1 transcriptional regulation, PDK1 
(pyruvate dehydrogenase kinase 1) plays a particularly essential role in metabolism 
by inhibiting the enzymatic complex PDH (pyruvate dehydrogenase).108 This 
ensures that pyruvate will not be converted into acetyl-CoA, preventing it from 
entering the mitochondria and feeding the oxidative pathway, therefore favoring the 
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fermentative pathway (conversion into lactate).108 A study by Tan and colleagues 
using BMDM cells showed that PDK1 knockdown led to a decrease in aerobic 
glycolysis in M1 macrophages, reducing several aspects of its pro-inflammatory 
phenotype.65 In M2 macrophages, PDK1 knockdown led to an enhanced 
macrophage activation towards a more anti-inflammatory state.65 
Another major role for succinate in M1 macrophages is associated with its 
interference with the electron transport chain (ETC) in the mitochondria, 
contributing to increased levels of ROS production.101 Indeed, increased succinate 
mitochondrial levels can lead to excessive reduction in ETC complex II (succinate 
dehydrogenase),109 as seen in LPS stimulated macrophages100 and macrophages 
subjected to bacterial infections in general.110 Excessive reduction results in the 
induction of a reversed electron flow in the ETC (RTC), sending electrons towards 
complex I, which results in the increased production of superoxide anion,109 a 
reactive oxygen species, therefore contributing to the oxidative burst and 
subsequent anti-microbial effect in M1 macrophages.100,110 It has been shown in 
BMDM cells that inhibition of the reverse electron flow with Metformin or inhibition 
of complex I with Rotenone caused a decrease in both pro-IL-1β and ROS 
production in LPS stimulated macrophages, hindering the pro-inflammatory 
response in classically activated macrophages.111 This indicates that the reversed 
electron flow in the ETC caused by the increased succinate levels contributes to 
the inflammatory response not only by increasing ROS production in the complex 
I, but also through increased expression of pro-inflammatory cytokines like IL-1β.111  
Finally, TCA cycle impairment at SDH has implications in amino acid 
metabolism, namely via increased glutaminolysis and activation of the aspartate-
argininosuccinate shunt (AASS), as both are used as anaplerotic processes to 
keep the cycle running.102,112,113 The AASS in particular is considered to be an 
essential part of macrophage inflammatory response, as arginine and/or citrulline 
can fuel NO production via iNOS.102,114 On the other hand, in M2 macrophages, 
arginine is converted into ornithine and urea via arginase-1 (urea cycle), decreasing 
arginine’s availability for NO production via iNOS.115 Additionally, glutamine can 
also be a nitrogen supplier for the hexosamine biosynthesis pathway (HBP), which 
is a minor branch from the glycolytic pathway, producing UDP-Glc-NAc.102 A study 
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by Jha and colleagues showed that glutamine depletion or inhibition of N-
glycosylation in murine BMDMs is associated with decreased expression of M2 
phenotypic markers, indicating that glutamine catabolism is essential for M2 
polarization.102  
In spite of the well-established pro-inflammatory role of succinate, recent work 
has shown that SDH-mediated succinate oxidation is actually necessary for a pro-
inflammatory phenotype.100 By using dimethyl malonate (DMM), a competitive 
inhibitor for SDH, it was demonstrated that IL-1β mRNA and HIF-1 expression were 
lowered, while IL-10 was increased, reflecting a more anti-inflammatory 
phenotype.100 Hence, it is possible that SDH is not a real breakpoint in the TCA 
cycle of M1 macrophages as initially thought, and that succinate processing (and 
the efficiency of SDH oxidation) rather than succinate accumulation in itself, are 
important for the activation of macrophages in response to inflammatory stimuli.116 
 
1.1.3.3.2. Citrate metabolism in M1 macrophages 
Citrate can contribute to a pro-inflammatory state in macrophages due to its 
role as precursor of different mediators that are required for the inflammatory 
response, including prostaglandins (PG’s), NO and ROS.117 PG production 
depends on FA synthesis, where citrate may be used as substrate.117 When citrate 
is located in the cytosol, it can be converted into acetyl-CoA and oxaloacetate, 
triggered by the cytosolic enzyme ATP-citrate lyase (ACLY).118,119 Acetyl-CoA is 
then used for fatty acid biosynthesis, providing the cell with PG precursors like 
arachidonic acid.117 A study by Infantino and colleagues using macrophages 
derived from human histiocytoma mononuclear cells (U937 cell line) showed 
increased expression in ACLY after activation with different combinations of pro-
inflammatory stimuli.119 This was associated with the signaling pathway involving 
TLR-4 stimulation by LPS and subsequent NF-kB activation, causing alterations in 
the transcription of several genes, including the genes coding for the enzyme 
ACLY.119 Considering that M1 polarization causes citrate accumulation in the 
mitochondrial matrix, and that ACLY is active in the cytosol, citrate first needs to be 
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transported from the mitochondria to the cytosol.117 This transportation is mediated 
by mitochondrial CIC (citrate carrier), which has been found to be upregulated in 
LPS-stimulated U937 macrophages.117 The other product obtained from citrate by 
ACLY is oxaloacetate, which is converted to malate and then to pyruvate via malic 
enzyme, resulting in the production of NADPH, another potential contributor to the 
inflammatory response due to increased production of NO and ROS, as already 
described.117,119 
Another metabolic route in which citrate can engage is the synthesis of itaconic 
acid (or itaconate), involving the mitochondrial enzyme cis-aconitic acid 
decarboxylase, encoded by the immune-responsive gene 1 (Irg1).120 Igr1 is one 
the most highly expressed genes in mammalian macrophages during inflammation, 
so it is not surprising that it plays an essential part in M1 metabolic processes.116 
The Irg1-coded enzyme catalyzes the conversion of cis-aconitate, an intermediate 
of the TCA cycle, into itaconate.121 This metabolite has been associated with some 
anti-microbial functions, including the inhibition of the bacterial enzyme isocitrate 
lyase, which is important for the glyoxylate shunt in both bacteria and fungi.63,116  
Recently, itaconate has also been postulated to modulate macrophage 
inflammatory response by controlling succinate levels and TCA cycle 
remodeling.116,122 In particular, in RAW 264.7 macrophages, itaconate was shown 
to act as an endogenous inhibitor of SDH, causing succinate accumulation.122 In 
another study, addition of exogenous itaconate to BMDM macrophages was shown 
to decrease their pro-inflammatory profile, as assessed by the downregulation of 
an array of pro-inflammatory transcripts.116 Altogether, the available data highlights 
a major regulatory role for itaconate regarding succinate levels, mitochondrial 
respiration and cytokine production in inflammatory macrophages. Additionally, a 
recent study by Mills and colleagues showed that the activation of transcription 
factor Nrf2 is required for its anti-inflammatory effects, where itaconate is 
associated with the alkylation of cysteine residues in proteins, which enable Nrf2 
to increase the expression of anti-inflammatory and anti-oxidant genes.123 
Administration of itaconate and a cell-permeable itaconate derivative (4-octyl 
itaconate) to LPS-stimulated human and murine macrophages (PBMC and BMDM, 
respectively), resulted in a decrease in Il1b mRNA and pro-IL-1β and HIF-1 protein 
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levels, indicating a potential anti-inflammatory effect caused by this derivative.123 
This anti-inflammatory potential was also observed in vivo, where 4-octyl itaconate 
prolonged survival and decreased TNF-α and IL-1β levels in an LPS model of 
sepsis.123   
The main idea to be summarized here is that TCA cycle rewiring is essential 
for defining differential macrophage phenotypes and effector functions. This 
rewiring sets a major role for several TCA cycle metabolites, with particular 
relevance given to citrate, itaconate, succinate and fumarate, which are essential 
as signaling molecules and immunomodulators. Taking in consideration that M2 
macrophages do not display this complex TCA cycle rewiring, these metabolic 
differences may be interpreted as hallmarks for macrophage classical activation. 
 
1.1.3.4. Fatty acid metabolism in activated macrophages 
Several review articles mention fatty acid oxidation (FAO) and FA synthesis as 
metabolic regulators in activated macrophages, indicating that lipid metabolism has 
an intricate and multifaceted role on these cells.60–63,70  Increased FAO is commonly 
described as an important feature of M2 macrophages,61,62 to sustain their 
energetic needs and anti-inflammatory activity.70 However, the dependence of M2 
macrophages on FAO has been challenged by some studies.71,124 A study 
conducted by Namgaladze and colleagues showed that while FAO was deemed 
necessary for IL-4 mediated M2 phenotype establishment in murine macrophages, 
it was dispensable in human macrophages (differentiated from monocytes isolated 
from buffy coats).71 By inhibiting carnitine palmitoyltransferase 1A (CPT1A - one of 
the enzymes involved in FAO that oxidizes palmitate), they showed that despite 
FAO not being active in the cell, there was no suppression in M2 macrophage 
phenotype expression, which implies that lipid metabolism and its regulation can 
have considerable differences between species.71 Fatty acid metabolism has also 
been implicated in the pro-inflammatory response of M1 macrophages, being linked 
with increased secretion of pro-inflammatory cytokines (like IL-1β and IL-18) 
through activation of the NLRP3 inflammasome.62,125 A study by Moon and 
colleagues using murine BMDMs and human PBMCs showed that by inhibiting 
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CPT1A, a decrease in IL-1β and IL-18 was observed, associated with NLRP3 
inflammasome suppression.125 The mechanism involved in NLRP3 activation is 
related to mitochondrial ROS production, where palmitate oxidation by CPT1A fuels 
mitochondrial respiration.125 Additionally, fatty acid synthase (FAS), an essential 
enzyme associated with lipogenesis, has also been implicated in this signaling 
pathway, where its inhibition resulted in NLRP3 suppression in vivo and in a 
consequential decrease in IL-1β and IL-18.126 
In line with these findings, the possibility of targeting macrophage metabolism 
to modulate macrophage activation and functions emerges as a promising novel 
strategy that may provide therapeutic benefit in the context of exacerbated 
inflammation-related disorders and other conditions where persistent inflammation 
is found.36,127 
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 Immunomodulatory effects of bioflavonoids  
The search for naturally occurring compounds that display potential therapeutic 
benefit has harnessed growing interest in various fields of research, including 
immunology, as many existing immunoregulatory drugs are commonly associated 
with potentially serious side effects due to their high toxicity.128 
One group of natural compounds that has shown great potential in terms of 
immunomodulatory effects are bioflavonoids.129–131 In this thesis, the cellular 
responses of human macrophages to three naturally occurring flavonoids was 
investigated, namely Quercetin, Naringenin and Naringin. Previous knowledge on 
their effects towards macrophage activation and metabolism is summarized below.  
 
1.2.1. Bioflavonoids 
Bioflavonoids are naturally occurring polyphenolic secondary metabolites that 
are commonly found in plants.130,132 These compounds have been the focus of 
many studies with the intent of establishing their various biological and 
pharmacological activities, including anti-inflammatory, anti-cancer, antioxidant, 
anti-microbial, anti-diabetic, anti-ulcer and anti-stress activities.129–134 
Flavonoids basic structure consists of three carbon rings (C6-C3-C6), more 
specifically, a benzene ring (A) and a phenyl ring (B), connected by a 3-carbon ring 
(C) (Figure 4).132 The majority of flavonoids found in nature are in their glycosylated 
form, with a sugar moiety linked to the flavonoid aglycone, while also commonly 
featuring methylated groups, contributing to the immense diversity seen in existing 
flavonoids.134 These compounds can be further divided into sub-categories 
according to the C ring carbon to which the B ring is linked, and regarding the 
degree of saturation and/or oxidation of the C ring.135 When the B ring is linked to 
carbon 3 of the C ring, the compound is classified as an isoflavone and when the 
link is to the carbon 4, a neoflavonoid.135 Regarding linkage to position 2, several 
other subcategories exist depending on the C ring structure.135 These include, for 
example, favonols, flavanones, flavones, chalcones and flavanols.132,135 
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Quercetin, one of the compounds assessed in this study, is an example of a 
flavonol, meaning that in addition to a ketone group in the C ring, it also possesses 
a hydroxyl group at position 3.135 This specific flavonol additionally displays 
hydroxyl groups positioned at carbons 3, 5, 7, 3’ and 4’ (Figure 4), and is very 
common in various fruits and vegetables.135,136 Other examples of common 
flavonols found in nature include Kaempferol and Myricetin, which all display a wide 
array of diverse biological effects, that can be explored as potential therapeutic 
strategies in various health conditions.137–139 
 
 
 
 
 
 
Figure 4: A – Schematic representation and numbering system of a generic flavonoid 
structure, with the B ring linked to the C ring in the position 2; B – Schematic representation 
and numbering system of the flavonol Quercetin. Adapted from132,135.  
 
 
 Other compounds selected for this study include the flavanone Naringenin 
and its O-glycosylated form, Naringin, which contains two rhamnose molecules 
linked to the aglycone at the carbon 7 of the A ring (figure 5).140 Structurally, 
flavanones have a distinct complete saturation of the C ring but are otherwise 
similar to flavones.135 Other common flavanones with potential health benefits 
includes Hesperetin and its glycosylated form, Hesperidin. These compounds are 
very common in citrus fruits and are known for their properties regarding free-
radical scavenging, anti-inflammatory effects and cholesterol lowering effects.135,141  
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Figure 5: A – Schematic representation and numbering system of flavanone aglycone 
Naringenin; B – Schematic representation and numbering system of the Naringenin 7-O-
glycoside, Naringin. Adapted from135,140 
 
 
1.2.2. Effects of bioflavonoids on macrophage polarization  
As mentioned earlier, one of the biological effects commonly described for 
flavonoids is immunomodulation, with particular interest in their anti-inflammatory 
potential.142 The assessment of the modulation of M1/M2 polarization by these 
compounds is therefore a promising strategy to evaluate the therapeutic potential 
of bioflavonoids.143 This modulation can be observed through different cellular 
alterations, including changes in signaling pathways, cytokine profile, gene 
expression and metabolism.142 
One of the most common changes seen in inflammatory macrophages upon 
treatment with flavonoids is the reduction of key pro-inflammatory cytokines, 
indicating a certain level of suppression of the pro-inflammatory 
phenotype.131,144,145 A study by Lee and colleagues showed that pre-treatment with 
Quercetin or Galangin of LPS-stimulated RAW 264.7 macrophages, led to a 
decrease in both IL-6 and NO levels, which are frequently associated with a pro-
inflammatory phenotype and considered M1 polarization markers in some 
macrophage cell lines (e.g. RAW 246.7).9,10,145 This indicates that pre-treatment 
with these flavonoids slightly hampers macrophage polarization towards the M1 
phenotype, therefore displaying some anti-inflammatory activity.145 NO 
suppression by Quercetin was also described in several other studies, both in vitro 
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and in vivo.146–150 A study by Qureshi and colleagues showed that peritoneal 
macrophages stimulated with LPS had significantly lower levels of NO when mice 
were fed Quercetin and δ-tocotrienol before isolation, which further establishes the 
potential anti-inflammatory effects of Quercetin.147 Additionally, a study by Raso 
and colleagues showed that among several flavonoids tested, Apigenin and 
Quercetin showed the most potent inhibitory effects on NO production.149 
Another common M1 marker that seems to be susceptible to alterations in 
response to treatment with certain flavonoids is TNF-α. A study by Manjeet and 
colleagues showed that both NO and TNF-α levels were decreased in LPS-
stimulated murine macrophages when co-cultured with Quercetin.150 Additionally, 
Zhang and colleagues showed that treating LPS-stimulated human THP-1 and 
murine J774 macrophages with the flavone Apigenin led to a decrease not only in 
TNF-α levels, but also in the pro-inflammatory interleukins IL-6 and IL-1β.151 
Naringin has also been shown to be effective at decreasing several pro-
inflammatory markers in LPS-stimulated macrophages. A study by Liu and 
colleagues showed a decrease in IL-8, MCP-1 and MIP-1α in RAW 264.7 murine 
macrophages pre-treated with Naringin, possibly by blocking the NF-kB signaling 
pathway.152 Others have also shown a decrease in TNF-α and decreased sepsis-
induced death in mice after treatment with Naringin, which clearly demonstrates its 
protective effects against inflammatory disorders.153 
The anti-inflammatory effects of flavonoids can also be seen in several disease 
models that are coupled with dysregulation of the inflammatory process, with 
beneficial effects on wound healing, tissue regeneration and reducing fibrosis in 
the affected tissues.143,154,155 Naringenin has been shown to reduce the severity of 
skin inflammation in mice with skin dermatitis, with several M1 markers being 
suppressed and an increase in IL-10, an M2 marker, being found in macrophages 
present in skin sections.155 A study using mice with induced liver damage showed 
that orally administrated Quercetin was not only able to reduce inflammation, but 
also the extent of necrotic tissue.154 This was accompanied by a marked decrease 
in several pro-inflammatory cytokines associated with macrophages present in the 
fibrotic tissue of the liver.154 In a mouse model of kidney injury, Quercetin also 
showed protective action, reducing both inflammation and fibrosis, while 
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suppressing M1 polarization, thus protecting renal function.143 Interestingly, in both 
liver and kidney damage models in vivo models, and in in vitro assays, Quercetin 
promoted a decrease in M2 macrophage populations.143,154 
 
1.2.3. Effects of bioflavonoids on macrophage energy metabolism 
Considering how different metabolic programs are involved in the 
establishment of the functional phenotypes of activated macrophages, targeting 
specific metabolic processes or signaling pathways involved in upstream regulatory 
mechanisms has been recognized as an interesting approach to modulate 
macrophage polarization.156 Given the effects reported for several bioflavonoids on 
macrophage immunomodulation, and the key role of metabolism in macrophage 
polarization, investigating how flavonoids affect macrophage metabolism may shed 
light on their mechanisms of action and open new prospects regarding their 
therapeutic potential. 
Most studies reported so far have focused on the modulation of signaling 
pathways that play an important role in metabolism regulation.157–159 One of the 
signaling pathways that is frequently reported to be modulated by bioflavonoids is 
the adenosine monophosphate-activated protein kinase (AMPK) signaling 
pathway.157,159–161 AMPK is a major regulator of glucose and lipid metabolism, 
acting as an energetic sensor that triggers the upregulation of energy-restoring 
catabolic pathways like FAO and OXPHOS, while downregulating glycolysis and 
switching off energy-consuming biosynthetic processes.162,163 Several studies 
support an anti-inflammatory role for AMPK activation, which may be achieved by 
a variety of small-molecule compounds.159–162 A study by Zhou and colleagues 
showed that administrating Eupatilin, a natural flavone, led to a decrease in several 
pro-inflammatory markers in THP-M human macrophages, partly via the activation 
of AMPK signaling pathway.160 Additionally, a study by Dong and colleagues 
showed that Quercetin inhibited the polarization of BMDM macrophages by 
activation of AMPK.159 This was confirmed by using an AMPK inhibitor, Compound 
C, which showed that one of the mechanisms through which Quercetin could 
abrogate the inflammatory response caused by LPS stimulation was indeed 
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through AMPK activation.159 Another flavonoid that has been reported to activate 
AMPK is Naringenin,157,160 both in murine RAW 264.7 macrophages161 and human 
THP-1 macrophages,157 contributing to the regulation of inflammation.157,161 
Regulation of glucose metabolism has also been associated with other signaling 
pathways, such as the phosphoinositide 3-kinase (PI3K) pathway164 and Mitogen-
Activated Protein Kinase (MAPK) pathway.165 Considering how these pathways 
have been shown to promote glycolysis,165,166 and are associated with LPS 
stimulation,91,166 their inhibition could potentially be a therapeutic strategy in 
regulating inflammation.62 A study by Si and colleagues showed that Quercetin was 
able to reduce levels of several pro-inflammatory markers, such as NO, IL6, IL-1β 
and TNF-α, in LPS-stimulated murine RAW 264.7 macrophages, coupled with a 
significant decrease in phosphorylation of MAPK signaling proteins.167 This 
indicates that Quercetin has a suppressing effect on the MAPK signaling pathway, 
which could contribute to the attenuation of the inflammatory phenotype in LPS-
induced macrophages.167 Another study by Endale and colleagues also showed 
this suppressing effect of Quercetin on the MAPK signaling pathway, which 
resulted in decreased levels of downstream pro-inflammatory mediators in LPS-
stimulated murine RAW264.7 macrophages.158 In this study, pre-treatment with 
Quercetin also suppressed the increase in PI3K and Akt that are commonly 
associated with LPS stimulation,91 corroborating the potential of Quercetin to 
attenuate macrophage inflammatory response.158  
Despite the suggested links between flavonoids anti-inflammatory action and 
their effects on cellular metabolism, little is known on the specific metabolites and 
metabolic pathways that are modulated upon flavonoid treatment. In this thesis, 
metabolomics was used as an advanced tool to further investigate this scientific 
question. 
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 Metabolomics  
1.3.1. Metabolomics strategies and tools 
The comprehensive profiling of the inventory of small molecules (< 1 kDa) acting 
as substrates, intermediates or products of enzymatic reactions in mammalian 
cells, through metabolomics, has become an extensively applied methodology to 
seek for a better understanding of cell metabolism and function.168 Metabolomic 
studies typically encompass identification and quantification of metabolites within 
tissues, biofluids or cells, and assessment of their variations in relation to a specific 
pathophysiological condition or external stimulus.169,170 Unlike other conventional 
biochemical methods, which focus on a specific, pre-determined set of metabolites, 
metabolomics provides a broader, non-selective view of metabolic changes, 
potentially revealing unexpected effects and allowing for mechanistic hypothesis to 
be generated.171,172 
The two analytical methods most commonly used in metabolomics are Nuclear 
Magnetic Resonance (NMR) spectroscopy and Mass Spectrometry (MS).171 In the 
present work, 1H-NMR was the profiling technique employed. In spite of its low 
sensitivity, which remains one of its biggest downsides, NMR does show important 
advantages, such as the possibility of acquiring data without requiring extensive 
sample treatment, the ability to identify metabolites of different chemical families in 
complex mixtures, high reproducibility and its non-destructive character.173 
Moreover, as the area of a signal is proportional to the number of protons giving 
rise to that signal, 1H-NMR is inherently quantitative, enabling a straightforward 
assessment of quantitative variations in selected metabolites.171,174,175 
1H-NMR spectra of biological samples are usually complex, containing a very 
high number of signals which can be attributed to specific metabolites based on 
their chemical shifts (in ppm) and multiplicity, by comparing the information derived 
from 1D and 2D spectra with that available in spectral databases.171,175  
To deal with such complexity and enable the multiparametric comparison of 
sample groups (e.g. control vs. treated) multivariate analysis (MVA) is commonly 
employed. This type of analysis considers the vast group of variables of each 
spectrum, allowing the user to assess the differences/similarities between spectra 
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of several samples.171 The two most common MVA methods used in metabolomics 
are: (i) principal component analysis (PCA) and (ii) partial least squares 
discriminant analysis (PLS-DA). The first is a non-supervised method, which offers 
a general idea of separation patterns arising from the various sources of variability 
within the dataset, without any input regarding sample classes. The latter 
maximizes the separation between sample classes, allowing the variables 
(metabolites) responsible for class discrimination to be highlighted.171,176 
 
1.3.2. Metabolomic studies of macrophage polarization  
 The metabolome of macrophages has been investigated in several previous 
studies, comprising the search for metabolic alterations upon different stimuli and 
in different macrophage cell lines (Table 2).75,168,177–187 Some studies have 
addressed the characterization of metabolic alterations associated with canonical 
M1 macrophage polarization, using LPS alone or in co-incubation with IFN-
γ.75,168,177  In line with molecular studies, the main changes detected reflected 
glycolysis upregulation and TCA cycle disruption.75,168,177  Others have investigated  
how macrophage metabolism and polarization were affected by direct exposure to 
pathogenic microorganisms (bacteria, parasites or viruses).178–181 For instance, 
exposure of THP-1 macrophages to Mycobacterium tuberculosis was associated 
with changes in several biosynthetic pathways, including GSH, carbohydrate and 
lipid synthesis, while showing also decreased levels of amino acids and 
monoacylglycerols.178,179 In another study, exposure of murine BMDMs to a 
parasite  (Leishmania major) was found to cause increases in lactate and several 
amino acids, which was putatively explained by the upregulation of glycolysis, 
consistent with a pro-inflammatory stimuli.180 Additionally, U1 macrophages 
chronically infected with HIV-1 virus showed changes in PPP metabolites and a 
reduced ability to generate NADPH, which could indicate a compromised capacity 
to generate de novo nucleotides and fatty acids.181  
The metabolomic response of macrophages to pollutants and nanoparticles 
has also been addressed in a few studies.184–186  Sapcariu and colleagues showed 
that exposing RAW 264.7 macrophages to HFO (heavy fuel oil) resulted in a shift 
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towards a more pro-inflammatory phenotype, with metabolic hallmarks like 
succinate and itaconate being elevated.184 Similarly, a study conducted by Zhao 
and colleagues showed that the emerging pollutant bisphenol S (BPS) also had a 
pro-inflammatory polarizing effect in J774A.1 macrophages, with particular 
emphasis given to an increased glycolytic rate and GSH biosynthesis.185 The 
effects of ultrasmall superparamagnetic iron oxide particles (USPIO), were 
assessed on LPS-induced M1 macrophages and comprised increases in succinate, 
pyruvate and lactate, consistent with increased glycolysis and aggravation of the 
pro-inflammatory phenotype.186 
Regarding macrophage exposure to natural compounds, metabolomics 
studies have investigated the effects of Deoxynivalenol (DON), Helenalin (HEL), β-
glucan and Glabridin (GB).182,183,187,188 Incubation of ANA-1 murine macrophages 
with DON resulted in changes in several metabolic pathways, specifically regarding 
glucose and amino acid metabolism.182 These changes included decreased levels 
of lactate and pyruvate, possibly indicating the downregulation of glycolysis.182 
Another study using THP-1 and PBMCs stimulated with HEL showed an increase 
in lactate production, accompanied by changes in several glycolytic and TCA cycle 
enzymes, together with an increase in ROS.183 Additionally, a study by Liu and 
colleagues showed that a yeast-derived β-glucan could convert anti-inflammatory 
tumor associated macrophages (TAM) into a more pro-inflammatory phenotype, 
displaying immunosuppressive and anti-tumoral effects.187 The metabolic changes 
accompanying this shift comprised of an upregulation of glycolysis, with increased 
levels of lactate, which would be consistent with a more pro-inflammatory 
phenotype. Other changes included increases in glutamine uptake and in GSH 
biosynthesis. As for the study involving the isoflavane Glabridin, it was shown that, 
in murine RAW264.7 macrophages, this flavonoid could revert some of the effects 
caused by LPS stimulation, particularly regarding pyruvate, alanine, aspartate and 
glutamate metabolism, as well as phenylalanine, tyrosine and tryptophan 
biosynthesis.188 
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The studies mentioned above illustrate the potential of metabolomics to 
characterize the changes in macrophage metabolism induced by various stimuli. 
However, to the best of our knowledge, comprehensive profiling of metabolic 
responses of human macrophages to bioflavonoids has not been reported before. 
In this thesis, NMR metabolomics is employed for the first time to assess 
macrophage metabolic reprogramming upon exposure to Quercetin, Naringin and 
Naringenin, three abundant bioflavonoids with well documented anti-inflammatory 
activity. This research is expected to advance current understanding of 
bioflavonoids mode of action, potentially supporting their future development as 
immunomodulatory drugs.  
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Table 2: Metabolomic studies of macrophage metabolism in response to different stimuli. 
 
 
Cells Stimuli 
Profiling 
technique 
Main findings References 
Canonical M1 polarization 
RAW 264.7 LPS CE/TOF-MS ↑TCA cycle intermediates 
↑Lactate 
[168] 
RAW 264.7 LPS GC-MS 
↑Itaconate 
↑Succinate 
↑Lactate 
[177] 
 
THP-1 
 
LPS+IFN-γ CE/TOF-MS 
↑Glycolytic metabolites 
↑PPP metabolites 
↓TCA cycle metabolites 
[75] 
Infectious microorganisms 
THP-1 
Mycobacterium 
tuberculosis 
GC/TOF-MS 
↓GSH anabolic 
metabolism 
↑Carbohydrate 
biosynthesis 
↓Lipid biosynthesis 
[178] 
THP-1 
Mycobacterium 
tuberculosis 
MS ↑Monoacyl glycerols 
↓Amino acids 
[179] 
 
BMDM 
 
Leishmania 
major 
NMR 
↑Lactate 
↑Amino acids 
↑Choline and derivatives 
[180] 
U1 HIV-1 LC-MS 
↑Pyruvate 
↑CTP and UTP 
↓6-P-gluconate 
[181] 
36 
 
 
Table 2 (continuation): Metabolomic studies of macrophage metabolism in response to 
different stimuli. 
 
Cells Stimuli 
Profiling 
technique 
Main findings References 
Pollutants 
RAW 
264.7 
Heavy Fuel Oil  
(HFO) 
GC/FTICR-MS 
↑Lactate 
↑Succinate 
↑Itaconate  
[184] 
J774A.1 Bisphenol S (BPS) LC-MS 
↑Glycolysis 
↑GSH biosynthesis 
[185] 
Nanoparticles 
RAW 
264.7 
Ultrasmall 
superparamagnetic 
Iron Oxides 
(USPIO) 
NMR 
↑Succinate 
↑Citrate 
↑Lactate 
↑Pyruvate 
[186] 
Natural compounds 
ANA-1 
Deoxynivalenol 
(DON) 
GC/TOF-MS 
↓Lactate  
↓Pyruvate 
↑Glycerol 
↑Linoleic acid methyl 
ester 
[182] 
THP-1 
PBMC 
Helenalin 
(HEL) 
2D gel 
electrophoresis 
TOF-MS 
NMR 
↓Serine 
↑Lactate 
↑ROS 
[183] 
BMDM 
TAM 
β-glucan GC-MS 
↑Glutamine uptake 
↑Glycolysis 
↑Lactate 
↑GSH biosynthesis 
[187] 
RAW 
264.7 
Glabridin 
(GB) 
GC-MS 
↓Pyruvate 
↓Aspartate 
↓Tyrosine 
↑Lactate 
↑Tryptophan 
[188] 
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 Objectives 
The main goal of this thesis is to assess how different bioflavonoids 
(Quercetin, Naringin and Naringenin) modulate the metabolism of human 
macrophages, with a view to better understand their mode of action, specifically 
regarding macrophage-mediated anti-inflammatory activity.  
Specific aims are: 
- To characterize the metabolome of THP-1-derived macrophages in uncommitted 
(M0), pro-inflammatory (M1) and anti-inflammatory (M2) activation states. 
- To assess the metabolic changes induced by Quercetin, Naringin and Naringenin 
and their dependence on: i) treatment time, ii) phenotype of treated macrophages 
(M0 vs. M1).  
- To propose hypotheses on metabolic pathways affected by flavonoid treatments 
and their role in the cells inflammatory state. 
- To advance current understanding of the metabolism-mediated 
immunomodulatory activity of bioflavonoids on human macrophages, envisaging 
their future application in the context of anti-inflammatory therapies. 
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2. Materials and Methods 
 Preparation of stock solutions 
All flavonoid stock solutions were prepared with 99.5% DMSO at a 
concentration of 80 mM. The flavonoids used were Quercetin (Alfa Aesar), 
Naringenin (Sigma Aldrich) and Naringin (Sigma Aldrich). These solutions were 
protected from light and kept at -20ºC for a maximum of two weeks. A stock solution 
of phorbol 12-myristate 13-acetate (PMA, Sigma Aldrich) was also prepared in 
99.5% of DMSO at a concentration of 100 µg/mL and protected from light at -20ºC. 
Considering the known cytotoxicity of DMSO to cells, all subsequent dilutions used 
in the various assays were prepared to have a maximum DMSO concentration of 
0.5% (v/v). Additionally, cellular viability assays showed that a DMSO concentration 
of 0.6% (v/v) did not significantly decrease cellular viability in this cell line. 
Powdered LPS (Sigma Aldrich) was dissolved in Gibco® Water for Injection 
(WFI) at a concentration of 1 mg/mL. Solutions of IFN-γ (BioLegend), IL-4 
(BioLegend) and IL-13 (BioLegend) were kept in the original formulation at a 
concentration of 0.1 mg/mL for IFN-γ and 0.2 mg/mL for IL-4 and IL-13. These 
solutions were also kept at -20ºC. Subsequent dilutions were prepared either with 
the appropriate cell culture media or with sterile PBS.  
 
 Cell culture maintenance 
Human monocytic THP-1 cells were obtained from the American Type Culture 
Collection (ATCC) and were cultured in suspension at 37ºC and a 5% CO2 
atmosphere, in RPMI 1640 (Roswell Park Memorial Institute Medium, Gibco) 
culture medium supplemented with 2.5 g/L of sodium bicarbonate (Sigma Aldrich) 
and containing 10% of heat inactivated FBS (fetal bovine serum) and 1 % of an 
antibiotic solution (penicillin and streptomycin). 
The cells were maintained in suspension in 100 mm non-adherent petri-
dishes. When cells reached a high confluency (about 80%), the cell culture media 
containing the cells was split into two new petri-dishes, to which fresh culture media 
was added. All experiments were performed with cells from passages 10 to 17. 
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 Cell viability assay 
The toxicity of the three flavonoids (Quercetin, Naringin and Naringenin) 
towards THP-1 derived macrophages was measured using an Alamar Blue® 
reduction assay. The active compound is resazurin (IUPAC name: 7-hydroxy-10-
oxidophenoxazin-10-ium-3-one), which is water-soluble, cell-permeable and non-
toxic to cells, thus being suitable for testing cell viability. In the presence of healthy 
cells, resazurin (a non-fluorescent blue die) works as an electron acceptor in the 
electron transport chain, where it is reduced to resorufin, which is highly fluorescent 
and pink-colored (Figure 6). The percentage of viable, metabolically active cells 
can then be estimated by measuring the emitted fluorescence.189 
To perform this assay, THP-1 monocytes were seeded in 96-well plates with 
5 x 104 cells per well in 200 µL of appropriate culture medium and differentiated 
into macrophages with 50 ng/mL PMA for 24h. Afterwards, cell media was removed 
and replaced with new media containing different concentrations of the test 
compounds (20, 40, 60, 80, 100, 150 and 200 µM). After different incubation times 
(6, 24 and 48h), cell media was removed again, and cells were incubated with 110 
µL of a 10% Alamar Blue® solution in cell media for approximately 24h. A 
microplate reader Sinergy HTX was then used to measure fluorescence (λEx = 
540nm; λEm = 600nm). 
 
 
 
 
Figure 6: Schematic representation of the reduction of resazurin, the active compound in 
an Alamar Blue® reduction assay, to resorufin, a highly fluorescent pink compound, in the 
presence of a highly reductive cellular environment. Adapted from190. 
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 Immunofluorescence staining of M1 and M2 macrophages 
THP-1 monocytes were seeded in IBIDI adherent plates at a density of 3×105 
cells/mL and differentiated with 50 ng/mL of PMA for 24h, followed by 24h with 
fresh media. Macrophages were then stimulated with 100 ng/mL of LPS + 20 ng/mL 
of IFN-γ for 24h or with 20 ng/mL of IL-4 + 20 ng/mL of IL-13 for 48h, to obtain M1 
and M2 polarized macrophages, respectively. 
After the appropriate incubation time, the cells were fixated with 4% formalin 
and washed with cold PBS (pH 7.4). Subsequently, 70 µL/well of  BSA were added 
to the cells for 30 min. BSA worked as a blocking agent to prevent non-specific 
binding of antigens and antibodies. After this step, cells were washed three times 
with PBS and then incubated for 1h with the appropriate antibodies. For assessing 
M1 markers, cells were incubated with 50 µL/well of mouse anti-human CD80 
(clone 2D10, conjugated with Alexa Fluor® 488) and mouse anti-human CD64 
(clone 10.1, conjugated with PE). M2 markers were assessed by incubating cells 
with 50 µL/well of mouse anti-human CD36 (clone 5-771, conjugated with PE) and 
mouse anti-human CD209 (clone 9E9A8, conjugated with FITC).  
The next step involved washing the cells three times with PBS (pH=7.4), 
followed by incubation with DAPI (4′,6-diamidino-2-phenylindole) for 15 min, at 
room temperature (RT), which is a blue-fluorescent die that stains  cells nuclei. The 
cells were then washed five times with PBS at RT and stored at 4ºC until 
visualization in 150 µL of PBS. When the cells were ready for visualization, the PBS 
was removed and replaced by mounting medium (DAKOTM), after which the cells 
could be observed in a fluorescence microscope (ZEISS AxioImager M2, equipped 
with a 10x/0.25 objective – Carl Zeiss, Germany). 
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 Cytokine quantification assay (LEGENDplex™ array) 
The production of several pro-inflammatory and anti-inflammatory cytokines 
was measured in the supernatants of THP-1 derived macrophages by a bead-
based multiplex assay LEGENDplex™ (BioLegend). The multiplex assay used was 
the Human M1/M2 Macrophage Panel (10-plex) with V-bottom Plate and allowed 
the quantification of 10 cytokines, including IL-12p70, TNF-α, IL-6, IL-10, IL-1β, 
TARC, IL-1RA, IL-12p40, IL-23 and IP-10. 
 
2.5.1. Reagent preparation  
Each vial of individual analyte beads was sonicated for 1 min and vortexed 
for 30 seconds. Then, aliquots of the 10 vials were mixed at equal volumes and the 
resulting mixture diluted 13 times with Assay Buffer (provided by the supplier). 
To prepare the standards, the lyophilized cytokine Standard Cocktail 
(provided by the supplier) was reconstituted in 250 µL of Assay Buffer, allowed to 
equilibrate at RT and transferred to a labeled polypropylene centrifuge tube. From 
this standard, serial dilutions (1:4) were performed to obtain different standard 
concentrations in the calibration curve. 
 
2.5.2. Assay procedure 
In each well of a 96-well V-bottom plate, 25 µL of Assay Buffer were mixed 
with 25 µL of standard or 25 µL of sample (cell culture medium supernatants). Then, 
25 µL of the beads mixture was added to each well, giving a total volume of 75 µL 
per well. The plate was subsequently covered with a plate sealer and aluminum foil 
to protect it from light exposure, and placed in a plate shaker at 750 rpm for 2h at 
RT. Next, the plate was centrifuged at 250g for 5 min, after which the supernatants 
were carefully discarded using a multi-channel pipette. After removing the 
supernatant, each well was washed with 200 µL of Wash Buffer (provided by the 
supplier). This was followed by a second centrifugation, after which the supernatant 
was again discarded.  
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The next step involved incubating each well with 25 µL of Detection 
Antibodies for 1h, having the plate covered with a plate sealer and aluminum foil, 
while shaking at 800 rpm at RT. After 1h, without washing the plate, 25 µL of 
streptavidin-phycoerythrin (SA-PE) was added to each well. The plate was again 
sealed, covered with aluminum foil, and placed in the plate shaker for another 30 
min, at RT. Afterwards, the plate was centrifuged in the same conditions as 
mentioned earlier, and the supernatant removed. This was followed by washing 
each well with 200 µL of Wash Buffer and a final centrifugation step. After removing 
the supernatant, 150 µL of Wash Buffer was added to each well and the beads 
were resuspended by pipetting.  
The samples were then analyzed in a flow cytometer (BD Accuri™ C6 plus 
(BD Biosciences), configured to acquire 4000 events in the region of interest (ROI) 
corresponding to the different beads and corresponding analytes. Data was gated 
and treated in LegendPlex software. 
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 NMR metabolomics assays 
2.6.1. THP-1 differentiation into macrophages 
The cell culture media containing the cells was transferred to 15 mL Falcon 
tubes and centrifuged at 300 xg for 5 min. The supernatant was then discarded and 
the pellet resuspended in 1 mL of fresh cell culture medium. The number of cells 
was counted using a Neubauer chamber, after adding 5 µL of the cell suspension 
to 45 µL of fresh medium and 50 µL of a trypan blue solution.  
 THP-1 monocytes were then seeded in adherent petri-dishes (10 cm 
diameter) at a density of 10×106 cells/mL and differentiated into macrophages 
through a 24-hour incubation with 50 ng/mL of phorbol 12-myristate 13-acetate 
(PMA). The cell media was then discarded and cells incubated with fresh media for 
another 24h, after which the monocytes were considered to have fully differentiated 
into adherent M0 macrophages. 
Macrophage M1 and M2 polarization was performed based on information 
found in literature,12,21 via a 24-hour incubation with 100 ng/mL of LPS and 20 
ng/mL of IFN-γ, and a 48-hour incubation with 20 ng/mL of IL-4 and 20 ng/mL of 
IL-13, respectively. 
 
2.6.2. Incubation of M0 and M1 macrophages with bioflavonoids 
 Uncommitted THP-1 derived macrophages (M0) were incubated with each of 
the three flavonoids for 6, 24 and 48h, at the highest non-toxic concentration found 
for each compound: Quercetin 60 µM, Naringenin 100 µM and Naringin 200 µM. 
These concentrations were determined through an Alamar Blue® cell viability 
assay, as described in section 2.3. Untreated M0 macrophages incubated for the 
same time periods were used as controls.  
 To evaluate the effects of these compounds on pro-inflammatory M1 
macrophages, the same concentrations were used to treat M1 macrophages. After 
a 24h incubation with 100 ng/mL LPS and 20 ng/mL IFN-γ, the medium was 
replaced by fresh medium containing each of the three flavonoids and cells 
incubated for additional 24h. M1-polarized macrophages cultured in fresh medium 
for 24h were used as controls. 
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2.6.3. Sample collection and preparation 
2.6.3.1. Cell culture supernatants 
Medium aliquots were collected from each petri-dish (including medium without 
cells incubated under the same conditions) and centrifuged at 1000 xg for 10 min. 
The supernatants were then collected and stored at -80ºC. To remove interfering 
proteins, thawed supernatants were then subjected to a protein-precipitation 
protocol described by Kostidis and colleagues.191 Briefly, 600 µL of cold methanol 
100% (v/v) at -80ºC were added to 300 µL of supernatant (1:3 proportion). The 
aliquots were then kept at -20ºC for 30 min, after which they were centrifuged at 
13000 x g for 20 min. The supernatant was then transferred to another vial, vacuum 
dried (SpeedVac, Eppendorf) and stored at -80ºC until NMR acquisition. 
At the time of analysis, the dried samples were resuspended in 600 µL of 
deuterated phosphate buffer (PBS 100 mM, pH 7) containing 0.1 mM 3-
(trimethylsilyl) propanoic acid (TSP-d4), and 550 µL of each sample were then 
transferred to 5 mm NMR tubes. 
 
2.6.3.2. Cell extracts 
To collect cell samples, the remaining medium was discarded from each dish 
and the cells washed 4 times with 10 mL of cold PBS. The intracellular metabolites 
were then extracted using a biphasic extraction protocol with 
methanol:chloroform:water (1:1:0.7). After adding1 mL of cold methanol (80% v/v) 
to quench metabolic activity of the cells, cells were scraped off the dish, transferred 
to a glass vial with 150 mg of glass beads (to aid in cell disruption) and vortexed 
for 2 min. Next, 400 µL of cold chloroform (-20ºC) was added to the tube and 
vortexed (2 min), followed by addition of 400 µL of chloroform and 360 µL cold milli-
Q water. The samples were vortexed, allowed to rest on ice for 20 min and 
centrifuged at 3000 xg for 10 min. The lower organic phase was transferred to an 
amber glass vial and the remaining sample subjected to another chloroform 
addition (400 µL) and centrifugation. The resulting organic phase was then added 
to the previous amber vial, while the top aqueous phase was transferred to a 
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microcentrifuge tube. Finally, the polar extracts were vacuum dried, and lipophilic 
extracts were dried under a nitrogen flow, after which they were stored at -80ºC.   
At the time of NMR analysis, the dried samples of the polar phases were 
resuspended in 600 µL of deuterated phosphate buffer (PBS 100 mM, pH 7) 
containing 0.1 mM TSP-d4, and 550 µL of each sample were then transferred to 5 
mm NMR tubes. The lipophilic phases were used in another Masters work 
addressing the lipidomic study of macrophages. 
A summarized schematic representation of the experimental protocol used in 
the section 2.6 can be found in Figure 7.  
 
Figure 7: Schematic representation of the experimental protocol used to obtain the 
aqueous, lipophilic and cell media samples of the THP-1 derived macrophages in each 
condition, as described in section 2.6. 
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 1H-NMR Spectroscopy 
All samples were analyzed in a Bruker Avance III HD 500 NMR spectrometer 
(University of Aveiro, PT National NMR Network) operating at 500.13 MHz for 1H 
observation, at 298 K. Standard 1D 1H spectra with water presaturation (pulse 
program ‘noesypr1d’, Bruker library) were recorded with 32k points, 7002.801 Hz 
spectral width, a 2 s relaxation delay and 512/2048 scans (for media/ polar extracts, 
respectively). Two-dimensional NMR spectra were also recorded for selected 
samples to aid metabolite identification, namely 1H-1H TOCSY, J-resolved and 1H-
13C HSQC spectra. Metabolite assignment was based on matching 1D and 2D 
spectral information to reference spectra available in Chenomx, BBIOREFCODE-
2–0–0 (Bruker Biospin, Rheinstetten, Germany) and HMDB.192,193 
Spectral processing was carried out using TopSpin 4.0.3 (Bruker Biospin, 
Rheinstetten, Germany). Each FID was multiplied by a cosine function (with an ssb 
value of 2), zero filled to 64k data points and Fourier-transformed. The resulting 
spectra were then manually phased, baseline corrected and calibrated to the TSP 
(δ 0 ppm) or the glucose (δ 5.235 ppm) signals, in media or polar extracts spectra, 
respectively. 
 
 Multivariate analysis of spectral data 
After processing, the spectra were visualized and prepared for multivariate 
analysis in Amix-Viewer 3.9.15 (Bruker Biospin, Rheinstetten, Germany). Each 
spectrum was normalized by its total area, excluding the water-suppression region 
and some contaminant signals, such as chloroform, ethanol and methanol. The 
normalized data were then organized into matrices (‘bucket tables’), containing the 
information on the signals intensity (variables) at each chemical shift  in the different 
spectra (observations).  
Data matrices were uploaded into SIMCA-P 11.5 (Umetrics, Umeå, Sweden), 
where PCA (Principal Component Analysis) and PLS-DA (Partial Least Squares- 
Discriminant Analysis) were applied. After testing different scaling types, unit-
variance scaling (UV), in which each column (containing the intensities at a 
49 
 
 
particular chemical shift) is divided by its respective standard deviation, was 
chosen. This procedure gives equal variance to all variables, allowing for variations 
in less abundant metabolites to have the same weight in multivariate models as 
more intense signals. The results were then visualized through factorial coordinates 
(‘scores’) and factorial contributions (‘loadings’) colored according to variable 
importance to projection (VIP). For PLS-DA models, Q2 and R2 values, respectively 
reflecting predictive capability and explained variance, obtained from sevenfold 
internal cross validation, were used to assess the robustness of class 
discrimination. 
 
 Spectral integration and univariate analysis 
Spectral integration of selected signals was carried out in Amix-Viewer 3.9.15 
(Bruker Biospin, Rheinstetten, Germany), to provide a quantitative measurement 
of metabolic variations. Signals representative of each metabolite that were found 
to be relatively free of overlap were integrated and normalized by the total spectral 
area. For each metabolite, the percentage of variation in treated samples was 
calculated relative to respective controls, along with the effect size (ES)194 and the 
statistical significance (p-value, as determined by the t-student test). The variations 
with medium-large magnitude (|ES|>0.5) were expressed in heatmaps colored as 
a function of % of variation, using the R-statistical software 
 
2.10. Statistical analysis 
The statistical analysis of both the metabolomics results and for the cytokine 
measurement of polarized M1 and M2 macrophages, were made via a t-student 
test, in which an approximation to normality was assumed, due to the small number 
of replicates. 
The statistical significance of the results for cytokine quantification in 
flavonoid treated macrophages and for the cell viability assay were assessed 
through a one-way ANOVA, with a Sidak multiple comparisons test.  
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3. Results and Discussion 
 Macrophage responses to canonical M1 and M2 stimuli 
3.1.1. Phenotypic characterization of M1 and M2 macrophages 
 Validation of M1 and M2 polarization states, induced, respectively, by a 24h-
incubation with LPS/IFN-γ and a 48h-incubation with IL-4/IL-13, was carried out 
through assessment of cell surface markers and cytokine expression. Based on 
existing literature,12,16,21 cell surface markers CD80 and CD64 were selected to 
assess M1 polarization, whereas CD36 and CD209 were used to evaluate M2 
polarization. Figure 8 shows the fluorescence microscopy images obtained for 
macrophages stimulated with M1 and M2 canonical stimuli. 
 
 
Figure 8: Fluorescence microscopy images of: a) LPS/IFN-γ–stimulated macrophages 
stained with CD64 (orange) - (CD80 no signal); b)IL4/IL-13-stimulated macrophages 
stained with CD209 (green) and CD36 (orange). Cell nuclei stained with DAPI (blue). 
 
Macrophages stimulated with IL-4 and IL-13 for 48h were positive for both 
CD36 and CD209, confirming that the conditions employed appeared to be 
adequate for obtaining M2 macrophages. Macrophages stimulated with LPS and 
IFN-γ for 24h were positive for CD64, but not for CD80. To further characterize 
macrophage phenotype, cytokine expression was assessed after stimulation, using 
flow cytometry with a multiplex assay specific for macrophages. The concentrations 
of the 10 cytokines measured (TNF-α, IL-1β, CXCL10, IL-23, IL-12p40, IL-12p-70, 
a) b) 
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IL-6, IL-10, CCL17 and IL-1RA) in each condition (uncommitted, LPS/IFN-γ and 
IL4/IL13-stimulated) are shown in Figure 9. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Concentrations of cytokines measured in the medium supernatants of polarized 
macrophages and their respective controls (n=3): a) M0 and M1 macrophages (24h) and 
b) M0 and M2 macrophages (48h).*p-value < 0.05; **p-value < 0.01. 
 
These results clearly show distinct cytokine profiles for differentially 
stimulated macrophages. The main variations in cell culture supernatants of 
LPS/IFN-γ-stimulated macrophages included increased levels of TNF-α, IL-1β, 
CXCL10, IL-12p40 and IL-6. These can all be considered pro-inflammatory 
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cytokines,10 although IL-6 has also been associated with alternative activation of 
macrophages, displaying a complex role in inflammation.195 Here, IL-6 increased 
markedly in M1 macrophages, whereas no significant variation was found in M2 
macrophages.  
In IL-4/IL-13-stimulated macrophages, the most evident variation included a 
significant increase in CCL17 levels, an anti-inflammatory chemokine commonly 
described as a biomarker of M2 polarization.16 Additionally, despite not being 
statistically significant, there appeared to be a tendency for an increase in IL-1RA, 
an IL-1 receptor agonist, which is also an established M2 polarization biomarker.16 
Other effects caused by M2 polarization included increased levels of IL-1β and of 
TNF-α, albeit to a much lesser extent when compared to M1 macrophages.  
Based on these results, and for the sake of simplicity, macrophages 
stimulated with LPS/IFN-γ (24h) or with IL-4/IL-13 (48h) will be designated 
hereafter as M1 and M2 macrophages, respectively. Unstimulated macrophages 
are referred to as M0 macrophages. 
 
3.1.2. Metabolic effects of canonical M1 and M2 stimuli 
The metabolic profile of macrophages was assessed by 1H-NMR 
spectroscopy. Figure 10 shows the 1H-NMR spectra of macrophage polar extracts 
obtained under different conditions (M0, M1, M2). Based on the analysis of 2D 
spectra recorded for selected samples (Figure 11) and matching to spectral 
databases, 46 metabolites were identified (Table S1 in Supplementary 
Information). These include several amino acids, organic acids, choline 
compounds, sugars, nucleotides, among others. Most of these metabolites were 
present in all sample groups, although differing in quantitative levels. An exception 
was found for itaconate, which was only present at detectable levels in M1 
macrophages, but not in M0 nor M2. 
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Figure 10: 500 MHz 1H-NMR spectra of polar extracts from a) M0, b) M1 and c) M2 
macrophages, with some metabolites assigned. 
a) 
b) 
c) 
ppm 
ppm 
ppm 
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Figure 11: Expansions of a) 1H-1H TOCSY and b) J-resolved spectra of a polar extract 
from M0 macrophages. Signals are numbered in accordance to table S1 (Supplementary 
Information). 
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To assess the metabolic changes induced in M1 and M2 macrophages relative 
to uncommitted M0 macrophages, their metabolic profiles were compared using 
multivariate analysis. The PCA scores scatter plots (Figure 12, left) showed a 
reasonable separation between either M1 or M2 macrophages and their respective 
controls. Such discrimination was confirmed by PLS-DA (Figure 12, middle), where 
high Q2 values were obtained.  
 
Figure 12: Multivariate analysis of 1H-NMR spectra from polar extracts of a) M0 and M1 
macrophages, b) M0 and M2 macrophages: PCA and PLS-DA scores scatter plots (left 
and center, respectively) and LV1 loadings w (right), colored according to variable 
importance to projection (VIP). 
 
By inspecting the PLS-DA loadings (Figure 12, right), it is possible to get an 
immediate picture of the main metabolic effects induced by canonical stimulation 
of THP-1 derived macrophages. As in both PLS-DA scores plot M1 and M2 
samples were grouped in the negative side of the LV1 axis, negative loadings 
correspond to metabolites increased in stimulated macrophages, whereas positive 
loadings correspond to metabolites elevated in controls. Then, based on spectral 
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integration, the magnitude and statistical significance in individual metabolite 
alterations highlighted in the PLS-DA loadings were further analyzed in more detail. 
These results are expressed in a heatmap (Figure 13) color-coded according to the 
percentage of variation of each metabolite in M1 and M2 macrophages relatively 
to their respective controls. Only variations with a medium-large magnitude 
(|ES|>0.5 according to Berben et al.194) were considered.  
 
Figure 13: Heatmap of the main metabolite variations in the polar extracts of M1 and M2 
macrophages. The color scale represents percentage of variation relative to respective 
controls (n=6). *p-value < 0.05; **p-value < 0.01.  
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The metabolites showing the most prominent (>20%) increases in M1 
macrophages were itaconate, succinate, citraconate, phosphoethanolamine, 
choline, glycerophosphocholine (GPC), ADP and lactate. Glycine and alanine were 
also increased in M1 macrophages (<20%). On the other hand, these 
macrophages showed decreased levels of several other metabolites, including 
marked decreases in NAD+, ATP, UTP, methylguanidine and isoleucine, and 
milder decreases in leucine, valine, myo-inositol, taurine, glutamine, GSH, citrate, 
N-acetyl aspartate, GSSG and phosphocholine (PC). 
In addition, M2 macrophage polarization was accompanied by a prominent 
increase in N-acetyl aspartate, lactate and myo-inositol, with UTP also showing a 
smaller increase. Moreover, glucose, taurine, succinate, GSSG, creatine and 
several amino acids (e.g. glutamine, glycine, alanine, asparagine) were decreased. 
Therefore, these results confirm that, as expected, M1 and M2 macrophages 
clearly differ in their intracellular metabolic composition.60,62,63 
Analysis of the cell culture medium provided complementary information on 
cells metabolic activity, allowing for a better interpretation of the variations 
observed in polar extracts. By comparing the metabolite composition of cell-
conditioned medium with that of acellular culture medium (incubated under the 
same conditions), the metabolites consumed and excreted by macrophages could 
be easily assessed. 
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Figure 14: Variations in consumption (negative bars) and excretion (positive bars) of 
several metabolites in the cell culture supernatant of THP-1 derived macrophages 
incubated with: a) LPS+IFN-γ for 24h (M1 polarization) and b) IL-4+IL-13 for 48h (M2 
polarization) when compared to acellular media (n=6). In both graphs, the red/purple  bars 
represent the polarized macrophages and the grey bars correspond to uncommitted 
macrophages at the respective incubation times. *p-value < 0.05; **p-value < 0.01. 
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As shown in Figure 14, the main substrates consumed by cells (negative 
percentual variation) were glucose, glutamine, pyroglutamate, phosphocholine, 
fructose, valine, leucine, isoleucine and glycine, whereas the metabolites with a 
positive percentage of variation, like alanine, 2-oxoisocaproate, 2-oxoisoleucine, 
glutamate, formate and lactate, were excreted into the extracellular medium.  
The graphs in Figure 14 also show the impact of M1 and M2 polarization on 
metabolite consumption/excretion patterns. Compared to M0 macrophages, M1 
macrophages showed: i) significantly increased consumption of glucose, ii) non-
significant trends for increased consumption of glutamine, branched chain amino 
acids and fructose, iii) significantly decreased excretion of formate, iv) non-
significant decrease in lactate excretion. 
On the other hand, relatively to their respective controls, M2 macrophages 
showed: i) non-significant trends for increased consumption of glucose, ii) 
significantly increased consumption of glutamine ang glycine, iii) significant 
increase in the excretion of asparagine, glutamate, formate and lactate, iv) non-
significant trends for increased excretion of 2-oxoisoleucine. 
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 Macrophage responses to bioflavonoids 
3.2.1. Flavonoid effects on cell viability 
To assess the effects of each bioflavonoid on cell viability and select 
appropriate concentrations for subsequent metabolomics experiments, THP-1 
derived macrophages were exposed for 24h to Quercetin, Naringenin and Naringin 
at concentrations ranging from 20 to 200 µM. The results of the Alamar Blue® 
reduction assay are shown in Figure 15. 
 
Figure 15: Cell viability of THP-1 derived macrophages exposed for 24h to: a) Quercetin; 
b) Naringenin; c) Naringin, at concentrations ranging from 20 μM to 200 μM, as assessed 
by the Alamar Blue® reduction assay. Statistical significance assessed in each 
concentration of the compound against the control (grey bar) via an ANOVA, with Sidak 
multiple comparisons test (n=5). *p-value < 0.05; **p-value < 0.01. 
 
 
Naringin was the flavonoid that showed the least cytotoxic effects, as cell 
viability/metabolic activity was above that of the control even at the highest 
concentration tested (200 μM). This effect could be in line with findings that 
Naringin is capable of stimulating cell proliferation and differentiation of bone 
marrow stromal cells (BMSCs), possibly also applying to macrophages.196 
Naringenin lowered cell viability at concentrations ≥150 µM. This is consistent with 
data obtained in a study by Saenz and colleagues, where the chosen concentration 
of Naringenin was 100 µM, which did not show any decrease in cell viability in THP-
1 derived macrophages.157 Finally, Quercetin lowered cell viability at 
concentrations ≥80 µM. Therefore, for each flavonoid, a non-cytotoxic 
concentration was chosen for subsequent experiments: i) 60 μM of Quercetin; ii) 
100 μM of Naringenin; iii) 200 μM of Naringin.  
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3.2.2. Phenotypic characterization of flavonoid-treated macrophages 
Out of the ten cytokines measured in cell culture medium using a multiplex 
assay, only six showed changes in concentration upon flavonoid treatment. These 
were TNF-α, IL-1β, CXCL10, IL-6, CCL17 and IL-1RA (Figure 16). Although most 
differences between sample groups did not reach statistical significance, likely due 
to a small number of replicates (n=3) and large standard deviation values, there 
were some clear variation trends. The pro-inflammatory cytokine TNF-α decreased 
for all tested flavonoids, with Naringenin having the most marked effects in M0 
macrophages. The levels of IL-1β were also affected, showing a decrease in the 
supernatants of treated pre-polarized M1 macrophages, with all three flavonoids 
having similar impact. In M0 macrophages, however, Quercetin treatment 
appeared to cause an increase in IL-1β, while no effects were caused by 
Naringenin or Naringin. The chemokine CXCL10, known as a pro-inflammatory 
mediator,14,58 was also decreased in both Quercetin and Naringenin-treated M0 
macrophages, while Naringin did not produce any noticeable effects. In pre-
polarized M1 macrophages, the levels of CXCL10 were very high in comparison to 
M0 macrophages and did not seem to be particularly affected by flavonoid 
treatment. Flavonoid treatment was also associated with a decrease in IL-6, in 
almost all conditions, albeit to a much lesser extent in M0 macrophages, especially 
in the case of Naringin treatment. This IL-6 lowering effect has been described for 
some flavonoids (including Quercetin and Naringenin), tested in LPS-stimulated 
RAW 264.7 macrophages, indicating an attenuated inflammatory response.197 
Regarding the anti-inflammatory chemokine CCL17, no changes were 
observed in flavonoid-treated M0 macrophages (the concentration was too low to 
be detected). In the case of pre-polarized M1 macrophages, CCL17 showed 
different variations depending on the flavonoid used. Quercetin and Naringin 
caused a decrease in CCL17 levels, whereas Naringenin led to an increase in this 
anti-inflammatory chemokine. Similarly, IL-1RA levels were also slightly increased 
in Naringenin-treated M0 macrophages, but decreased with Quercetin and Naringin 
treatment in both M0 and M1-like macrophages. 
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Figure 16: Concentration of pro- and anti-inflammatory cytokines in the medium 
supernatant of M0 macrophages and pre-polarized M1 macrophages upon 24h exposure 
to each flavonoid: a) TNF-α, b) IL-1β, c) CXCL10, d) IL-6, e) CCL17 and f) IL-1RA. 
Statistical significance was assessed using a one-way ANOVA, with a Sidak multiple 
comparisons test (n=3). *p-value < 0.5. 
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The results described above indicate that: i) all flavonoids tested induced 
decreased production of pro-inflammatory cytokines, corroborating their substantial 
reported activity in attenuating inflammation, ii) Naringenin could additionally act by 
increasing the expression of anti-inflammatory cytokines (as shown here for 
CCL17). 
 
3.2.3. Metabolic effects of Quercetin on M0 and M1 macrophages 
 The effects of Quercetin on the intracellular metabolome of THP-1 derived 
macrophages were assessed through 1H-NMR analysis of cell polar extracts, 
followed by multivariate analysis and spectral integration. The PCA and PLS-DA 
results obtained for the comparison between untreated M0 macrophages and 24h 
Quercetin-treated M0 macrophages are shown in Figure 17. The two sample 
groups were clearly separated in the scores plots, with a very high Q2 value 
(reflecting model robustness) being obtained for the PLS-DA model. Also, PLS-DA 
LV1 loadings (Figure 17, right) showed intense coloring of many variables, 
indicating the marked impact of Quercetin on macrophages metabolic profile. 
Positive loadings correspond to metabolites increased in samples grouping in 
positive LV1, i.e. the controls (e.g. lactate, GSH), whereas negative loadings arise 
from metabolites increased in samples with negative LV1 scores, i.e. Quercetin-
treated macrophages (e.g. glucose, citrate). Equally good MVA discriminations 
were also obtained for 6 and 48h treatments (Figure S1, Supplementary 
Information). 
Figure 17: Multivariate analysis of 1H-NMR spectra from the polar extracts of THP-1 
derived macrophages comparing unstimulated M0 macrophages (grey) and Quercetin-
treated macrophages (green) , incubated for 24h. PCA and PLS-DA scores scatter plots 
(left and center, respectively) and LV1 loadings w (right), colored according to variable 
importance to projection (VIP). 
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 In order to analyze in more detail the metabolic changes induced by 
Quercetin, spectral signals representing individual metabolites were integrated and 
the percentage of variation in each treatment group calculated relative to respective 
controls. The results obtained for Quercetin treatment of M0 macrophages during 
6, 24 and 48h are summarized in the heatmap shown in Figure 18. Additionally, 
Quercetin effects on pre-polarized M1 macrophages (incubated with LPS + IFN-γ 
for 24h and then stimulated with Quercetin for another 24h, after removing the 
medium containing the pro-inflammatory stimuli) is also shown in the heatmap. 
Overall, a 24h incubation with Quercetin appeared to have a more pronounced 
effect on the metabolic profile of THP-1 derived macrophages, and the effects seen 
in pre-polarized macrophages were, to some extent, similar to those observed in 
Quercetin-treated uncommitted macrophages. 
 Regarding the effects of Quercetin on M0 macrophages, most changes were 
common to all time points, albeit in different extents. In particular, the metabolites 
found to be consistently increased in treated macrophages were glucose, citrate, 
GSSG, methylguanidine, taurine, choline compounds and phosphoethanolamine, 
whereas lactate, succinate, several amino acids, phosphocreatine and GSH were 
decreased. Several of these changes were especially prominent in the 24h 
treatment. On the other hand, some variations were clearly time-dependent, 
namely those in aspartate (increased in macrophages treated for 6/24h, but 
decreased at 48h), ATP, UTP, valine, myo-inositol and formate.  
When macrophages were polarized to a pro-inflammatory (M1) state before 
Quercetin treatment, there were also a significant number of changes in the 
intracellular metabolome (Figure 18, column on the far right). Many of these 
changes were common to those produced by Quercetin in M0 macrophages, 
including the increases in citrate, (glycero)phosphocholine and 
phosphoethanolamine, together with decreases in lactate, succinate, amino acids 
and phosphocreatine. On the other hand, unlike Quercetin-treated M0 
macrophages, M1 macrophages showed no alteration in glucose, aspartate or 
GSSG intracellular levels upon Quercetin treatment. Additionally, an increase in 
itaconate (accompanied by a decrease in its predecessor citraconate) was 
detected in M1 Quercetin-treated macrophages. The results also indicate that the 
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variations in antioxidant metabolites and choline were opposite to those obtained 
for M0 treated macrophages. 
 
Figure 18: Heatmap of the main metabolite variations in the polar extracts of THP-1 
derived macrophages upon treatment with Quercetin (60 µM): M0 macrophages incubated 
with the flavonoid for 6, 24 or 48h; M1 pre-polarized macrophages incubated with the 
flavonoid for 24h. The color scale represents percentage of variation relative to respective 
controls (n=6). *p-value < 0.05; **p-value < 0.01. 
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The variations in cell culture medium composition (exometabolome) in 
response to Quercetin treatment of both uncommitted and pre-polarized M1 
macrophages are summarized in Figure 19. Overall, a higher number of significant 
changes were detected in 48h culture media samples. When exposed to Quercetin, 
uncommitted macrophages were found to excrete less lactate and formate 
ubiquitously in all incubation times, although reaching statistical significance only 
at 24 and 48h (Figures 19b and 19c, respectively). This effect was not present in 
Quercetin-treated M1 macrophages (Figure 19d), which actually showed a slight 
tendency of increased excretion of lactate. Similarly, glutamate excretion was 
decreased in Quercetin treated M0 macrophages, while pre-polarized 
macrophages showed increased excretion of glutamate upon incubation with 
Quercetin. Other differences in excreted metabolites include the reduced or ceased 
excretion of 2-oxoisoleucine in all groups, except for the 6h treated M0 
macrophages (Figure 19a), and the increased excretion of valine in the 24h 
Quercetin-treated groups (both M0 and M1). 
Interestingly, glucose consumption was affected in all conditions except in 
the cells treated for 6h, showing a tendency to decrease in 24h treated 
macrophages, a statistically significant decrease at 48h and a complete arrest of 
glucose consumption in pre-polarized M1 macrophages. A decrease in glutamine 
consumption could also be found in 48h treated macrophages and in pre-polarized 
macrophages. On the other hand, isoleucine was being less consumed in both 24h 
and 48h treated cells, whereas pre-polarized macrophages stopped consuming 
isoleucine and started excreting it to the extracellular media. Several other 
metabolites were found to be less consumed or not consumed at all, specifically in 
the 48h Quercetin treated macrophages, (e.g. glycine, leucine, valine, fructose, 
pyroglutamate, phosphocholine).  
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Figure 19: Variations in consumption (negative bars) and excretion (positive bars) of 
several metabolites in the cell culture supernatant of THP-1 derived macrophages 
incubated with 60 μM of Quercetin: a), b), c) M0 macrophages incubated with Quercetin 
for 6, 24 and 48h, respectively; d) Pre-polarized M1 macrophages incubated with Quercetin 
for 24h. Each Quercetin incubation (green bars) was compared to its respective control 
(grey bars). Statistical significance of variation was assessed via a t-student test (n=6): *p-
value < 0.05; **p-value < 0.01. 
a) b) 
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3.2.4. Metabolic effects of Naringenin on M0 and M1 macrophages 
 
The metabolic effects of Naringenin treatment in THP-1 derived 
macrophages were assessed using the same strategy as that described for 
Quercetin. 
Figure 20 shows the multivariate analysis performed on the 1H-NMR spectra 
of polar extracts collected for 24h Naringenin-treated M0 macrophages and their 
respective controls (results for other time points shown in Figure S2, 
Supplementary Information). The separation between the control group and the 
Naringenin-treated group is visible in both PCA and PLS-DA scores scatter plots 
(Figure 20, left and middle). PLS-DA LV1 loadings (Figure 20, right) immediately 
revealed the most marked effects induced by Naringenin (e.g. increases in lactate 
and some amino acids, together with decreases in GSH and 
glycerophosphocholine). 
 
Figure 20: Multivariate analysis of 1H-NMR spectra from the polar extracts of THP-1 
derived macrophages comparing unstimulated M0 macrophages (grey) and Naringenin-
treated macrophages (blue), incubated for 24h. PCA and PLS-DA scores scatter plots (left 
and center, respectively) and LV1 loadings w (right), colored according to variable 
importance to projection (VIP). 
 
 
 
 
71 
 
 
The quantitative analysis of individual metabolite variations in M0 
macrophages treated with Naringenin for different time periods, as well as in 24h 
Naringenin-treated pre-polarized M1 macrophages is summarized in the heatmap 
shown in Figure 21. Several metabolic effects of Naringenin in M0 macrophages 
appeared to be time-dependent, generally intensifying with treatment duration. For 
instance, gradual increases were found in the intracellular levels of glucose, lactate, 
N-acetylaspartate, some amino acids and (phospho)choline. Additionally, 
succinate was increased only in 48h Naringenin-treated macrophages (relative to 
respective controls). On the other hand, Naringenin treatment caused decreases 
in the intracellular levels of citrate, asparagine, aspartate, glycerophosphocholine 
and myo-inositol. Moreover, a few metabolites even showed opposite variations 
depending on the incubation period with Naringenin. This was the case of GSH, 
which increased in 6h treated cells (where the oxidized form GSSG was 
decreased), but then decreased for 24 and 48h. Also, ATP levels were increased 
in both 6 and 48h but decreased in 24h treated M0 macrophages. 
Interestingly, the metabolic signature of Naringenin in pre-polarized 
macrophages (Figure 21, column on the far right) showed several differences 
compared to the effects produced in M0 macrophages. In particular, opposite 
variations were found for glucose, lactate, succinate, (phospho)creatine, choline, 
asparagine and glutamine. Still, some Naringenin effects appeared to be 
independent of macrophage initial polarization state, namely the decreases in 
citrate, glycerophosphocholine and formate, together with the increases in NAD+ 
and glutamate. 
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Figure 21: Heatmap of the main metabolite variations in the polar extracts of THP-1 
derived macrophages upon treatment with Naringenin (100 µM): M0 macrophages 
incubated with the flavonoid for 6, 24 or 48h; M1 pre-polarized macrophages incubated 
with the flavonoid for 24h. The color scale represents percentage of variation relative to 
respective controls (n=6). *p-value < 0.05; **p-value < 0.01. 
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The variations in cell culture medium composition in response to Naringenin 
treatment of both uncommitted and pre-polarized M1 macrophages can be 
consulted in Figure 22. Similarly to the endometabolome, the differences induced 
by Naringenin in the exometabolome of M0 macrophages intensified over exposure 
time. Compared to untreated control macrophages, 48h Naringenin-treated 
macrophages consumed less phosphocholine, pyroglutamate and glutamine, while 
showing a non-significant trend to consume more glucose and/or fructose. Also, 
treated cells excrete less formate and glutamate, together with more alanine. 
Interestingly, the variations in cells nutrients consumption and metabolites 
excretion patterns upon Naringenin treatment were exacerbated when 
macrophages were pre-polarized to a pro-inflammatory M1 state (Figure 22d). 
Compared to respective controls (24h in fresh medium after LPS/IFN-γ stimulation), 
Naringenin-treated M1 macrophages displayed increased consumption of fructose, 
myo-inositol and some amino acids, accompanied by reduced use of glutamine and 
glucose. Notably, while M0 macrophages showed a trend for consuming more 
glucose in the presence of Naringenin, M1 macrophages arrested glucose 
consumption upon Naringenin treatment. Regarding the excretion pattern, 
Naringenin-treated M1 macrophages excreted more lactate and formate, but lower 
amounts of alanine and metabolites resulting from branched chain amino acids 
catabolism (2-oxoisoleucine and 2-oxoisocaproate). 
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Figure 22: Variations in consumption (negative bars) and excretion (positive bars) of 
several metabolites in the cell culture supernatant of THP-1 derived macrophages 
incubated with 100 µM of Naringenin: a), b), c) M0 macrophages incubated with Naringenin 
for 6, 24 and 48h, respectively; d) Pre-polarized M1 macrophages incubated with 
Naringenin for 24h. Each Naringenin incubation (blue bars) was compared to its respective 
control (grey bars). Statistical significance of variation was assessed via a t-student test 
(n=6): *p-value < 0.05; **p-value < 0.01 
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3.2.5. Metabolic effects of Naringin on M0 and M1 macrophages 
 
 Among the three flavonoids tested, Naringin was found to have the lowest 
impact on the endometabolome of THP-1 derived macrophages, despite the higher 
concentration used (200 µM). This can be clearly seen in Figure 23 showing the 
multivariate comparison of control and 24h Naringin-treated M0 macrophages. The 
two groups were not separated in the PCA scores scatter plot, and PLS-DA model 
robustness, as assessed by the Q2 value (0.582), was relatively lower. Also, few 
variables showed high VIP (importance to the projection), as demonstrated by the 
less intense colouring of LV1 loadings. Similar MVA results were obtained for 6 and 
48h exposures (Figure S3, Supplementary Information). Still, the spectra were 
integrated and the variations with larger magnitude (|ES| > 0.5) were represented 
in the heatmap shown in Figure 24. 
 
Figure 23: Multivariate analysis of 1H-NMR spectra from the polar extracts of THP-1 
derived macrophages comparing unstimulated M0 macrophages (grey) and Naringin-
treated macrophages (pink), incubated for 24h. PCA and PLS-DA scores scatter plots (left 
and center, respectively) and LV1 loadings w (right), colored according to variable 
importance to projection (VIP). 
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In agreement with the MVA results, the number of metabolites varying 
consistently with Naringin treatment was smaller when compared to the other 
bioflavonoids. Also, the magnitude of most variations  was relatively lower and 
differed according to the incubation time. In general, the longer the exposure of M0 
macrophages to Naringin, the more noticeable its effects were. 
Focusing on the changes detected at 24h of treatment, Naringin caused mild 
increases in NAD+, N-acetylaspartate, valine, ADP, creatine, GSSG, taurine and 
(phospho)choline, while decreasing the levels of aspartate, ATP and UTP, GSH, 
methylguanidine and glycerophosphocholine. Interestingly, some of these changes 
were also seen upon Naringin treatment of pre-polarized M1 macrophages (e.g. 
variations in creatine, GSH/GSSG and taurine), while others were absent or in the 
opposite direction. For example, glucose decreased in Naringin-treated M1 
macrophages, contrarily to the variation induced in M0 macrophages (at 6 and 48h 
incubations). Also, lactate and phosphocreatine, which did not vary in treated M0 
macrophages, decreased in M1 treated macrophage. 
 At the extracellular level, the changes induced by Naringin are summarized 
in Figure 25. Most significant changes were found when Naringin was given to pre-
polarized M1 macrophages (Figure 25d), comprising: decreased consumption of 
glucose (also seen in 48h Naringin-treated M0 macrophages), as well as glutamine 
and other amino acids; increased consumption of fructose; increased excretion of 
myo-inositol and ceased excretion of alanine, 2-oxoisocaproate and 2-
oxoisoleucine. 
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Figure 24: Heatmap of the main metabolite variations in the polar extracts of THP-1 
derived macrophages upon treatment with Naringin (200 µM): M0 macrophages incubated 
with the flavonoid for 6, 24 or 48h; M1 pre-polarized macrophages incubated with the 
flavonoid for 24h. The color scale represents percentage of variation relative to respective 
controls (n=6). *p-value < 0.05; **p-value < 0.01. 
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Figure 25: Variations in consumption (negative bars) and excretion (positive bars) of 
several metabolites in the cell culture supernatant of THP-1 derived macrophages 
incubated with 200 µM of Naringin: a), b), c) M0 macrophages incubated with Naringin for 
6, 24 and 48h, respectively; d) Pre-polarized M1 macrophages incubated with Naringin for 
24h. Each Naringin incubation (pink bars) was compared to its respective control (grey 
bars). Statistical significance of variation was assessed via a t-student test (n=6): *p-value 
< 0.05; **p-value < 0.01  
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3.3. Integration and discussion of macrophage metabolic changes 
The 1H-NMR metabolomics approach employed in this thesis enabled the 
detection of multiple changes in the metabolic profile of human THP-1-derived 
macrophages in response to different stimuli, including treatment with three 
bioflavonoids (Quercetin, Naringenin and Naringin). This section is now aimed at 
comparing and discussing those variations in the context of some major metabolic 
pathways operating in cells. 
3.3.1. Effects on glucose uptake and glycolysis 
The impact of the different treatments on cells glycolytic activity can be 
inferred from changes in glucose and lactate levels (Figures 26 and 27, 
respectively). Glucose consumption increased in both M1 and M2 macrophages, 
with M2 additionally showing decreased intracellular glucose levels (Figure 26d). 
Moreover, compared to their respective controls, M1 and M2 macrophages 
displayed considerably higher levels of intracellular lactate (Figure 27d), and in the 
case of M2, increased lactate excretion (Figure 27a). These results are consistent 
with the high glucose uptake and glycolytic activity reported for activated 
macrophages.60–63 Interestingly, though, we found no evidence of glycolytic 
upregulation being more extensive in M1 than in M2 macrophages.  
Quercetin treatment lowered glucose consumption in M0 macrophages but 
was accompanied by a marked increase in intracellular glucose levels (Figures 26b 
and 26d). Moreover, Quercetin-treated M0 macrophages displayed reduced 
extracellular and intracellular levels of lactate (Figures 27b and 27d). These 
alterations suggest that: i) glucose was less taken up by treated cells, ii) its 
glycolytic conversion into lactate was downregulated, leading to intracellular 
glucose accumulation. In the case of Quercetin-treated M1 macrophages, glucose 
uptake was completely inhibited (Figure 26c), which is possibly related to slightly 
decreased intracellular lactate levels (Figure 27d). Overall, these results are in line 
with the inhibitory effects of Quercetin towards the glucose transporter GLUT1, 
reported for different tumor cells.198 
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The effects of Naringenin on glucose uptake and metabolism greatly 
depended on the initial polarization state of macrophages (M0 or M1). Naringenin-
treated M0 macrophages showed a trend for increased glucose consumption and 
intracellular glucose levels (Figures 26b and 26d), together with increased 
extracellular and intracellular lactate levels (Figures 27b and 27d). This suggests 
upregulated glucose uptake and subsequent glycolytic conversion into lactate. On 
the other hand, when Naringenin was given to pre-polarized M1 macrophages, the 
main effect appeared to be inhibition of glucose uptake (accompanied by 
decreased intracellular glucose and lactate levels). Similarly, Naringin also 
decreases glucose uptake, especially in pre-polarized M1 macrophages (Figure 
26c), where decreased intracellular glucose and lactate were also visible (Figures 
26d and 27d). 
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Figure 26: Extracellular (a-c) and intracellular (d) variations of glucose levels in 
macrophages incubated under different conditions, relative to respective controls (n=6). 
*p-value < 0.05; **p-value < 0.01. 
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Figure 27: Extracellular (a-c) and intracellular (d) variations of lactate levels in 
macrophages incubated under different conditions, relative to respective controls (n=6). 
*p-value < 0.05; **p-value < 0.01. 
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3.3.2. Effects on the TCA cycle 
One of the metabolic effects most commonly reported for different 
macrophage cells lines when subjected to a pro-inflammatory stimulus consists of 
increased levels of itaconate and succinate, which have been associated with a 
truncated TCA cycle.62 Such increases were indeed verified in the present study 
upon stimulation of THP-1 derived macrophages with LPS/IFN-γ (Figure 28). Other 
TCA cycle intermediates that varied in M1 macrophages were citraconate, which is 
a structural isomer of itaconate,199 and citrate (decreased in M1 vs. M0 
macrophages). In M2 macrophages, neither itaconate nor citraconate levels were 
altered, but there was a decrease in both citrate and succinate. This is consistent 
with a functional TCA cycle, corroborating existing evidence that M2 macrophages 
rely not only on glycolysis, but also on the TCA cycle and oxidative phosphorylation  
for energy production,60,62 delineating one of the differences between the metabolic 
profiles of M1 and M2 macrophages. 
Quercetin treatment of M0 macrophages resulted in decreased levels of 
succinate, which is a TCA cycle intermediate with an established pro-inflammatory 
role.97 Hence, attenuation of succinate by Quercetin in both M0 and M1 
macrophages could be a good indicator of Quercetin’s ability to attenuate 
macrophage-mediated inflammation. Additionally, Quercetin-treated M0 
macrophages showed a huge increase of intracellular citrate, which was not 
channeled into itaconate production as reported for M1 macrophages.122,177 
Instead, citrate accumulation could possibly reflect its impaired use in fatty acid 
synthesis,117 an hypothesis that requires proper testing  in the future. In Quercetin-
treated M1 macrophages, citrate increased to a lesser extent and itaconate levels 
were higher compared to M1 control cells (incubated for 24h in fresh medium after 
LPS/IFN-γ stimulation). Given that itaconate is currently recognized as an anti-
inflammatory metabolite,116,122 this variation corroborates the role of Quercetin in 
reducing inflammation via metabolic reprogramming. 
In Naringenin-treated macrophages, succinate only decreased after M1 pre-
polarization (no change in 24h treated M0 macrophages). Moreover, the variations 
in citrate, citraconate and itaconate were opposite to those observed for Quercetin, 
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suggesting different modulation of the TCA cycle by those flavonoids. Assessment 
of TCA cycle enzymes expression by using molecular biology tools would be useful 
to further understand this difference. 
Finally, no significant variations were found for Naringin-treated 
macrophages regarding TCA cycle metabolites. 
 
Figure 28: Intracellular variations of metabolites related to the TCA cycle in macrophages 
incubated under different conditions, relative to respective controls.: a) itaconate; b) 
succinate and c) citrate (n=6). *p-value < 0.05; **p-value < 0.01. 
 
 
 
%
 V
a
r
ia
ti
o
n
 (
v
s
. 
c
o
n
tr
o
l 
c
e
ll
s
)
M
1
 2
4
h
M
2
 4
8
h
M
0
+
Q
u
e
 2
4
h
M
1
 +
 Q
u
e
 2
4
h
M
0
+
N
g
n
 2
4
h
M
1
 +
 N
g
n
 2
4
h
-5 0
0
5 0
1 0 0
1 5 0
S u c c in a te
* *
* * * * *
* *
%
 V
a
r
ia
ti
o
n
 (
v
s
. 
c
o
n
tr
o
l 
c
e
ll
s
)
M
1
 2
4
h
M
2
 4
8
h
M
0
+
Q
u
e
 2
4
h
M
1
 +
 Q
u
e
 2
4
h
M
0
+
N
g
n
 2
4
h
M
1
 +
 N
g
n
 2
4
h
-2 0
0
2 0
4 0
2 5 0
5 0 0
Ita c o n a te
* *
* *
*
%
 V
a
r
ia
ti
o
n
 (
v
s
. 
c
o
n
tr
o
l 
c
e
ll
s
)
M
1
 2
4
h
M
2
 4
8
h
M
0
+
Q
u
e
 2
4
h
M
1
 +
 Q
u
e
 2
4
h
M
0
+
N
g
n
 2
4
h
M
1
 +
 N
g
n
 2
4
h
-4 0
-2 0
0
2 0
4 0
2 5 0
5 0 0
C itra te
* * * *
* *
* *
* *
* *
a) b) 
c) 
85 
 
 
3.3.3. Effects on amino acid metabolism 
Glutamine is another major fuel for macrophages, having been implied in 
macrophages phagocytic capacity,200 as well as in M2-polarization.102 Here, 
significant changes were observed on intracellular and extracellular levels of 
glutamine and glutamate, as shown in Figure 29. 
Regarding macrophage activation with canonical M1 and M2 stimuli, M2 
macrophages displayed considerably higher glutamine consumption and 
intracellular use (Figure 29 a,d). Glutamate was also decreased intracellularly in 
M2 macrophages. This could indicate that M2 macrophages took up more 
glutamine to fuel the TCA cycle through glutaminolysis, where glutamine is 
converted to glutamate and then to α-ketoglutarate, which has indeed been 
reported to be an important contributing factor to the alternative activation of 
macrophages.62,112 
Quercetin treatment of either M0 or pre-polarized M1 macrophages caused 
decreased intracellular levels of both glutamine and glutamate (Figure 29 d,e). 
Although in this case glutamine uptake from the cell culture medium was not 
increased, these changes could indicate intensification of glutaminolysis, as a 
means to fuel the TCA cycle.62 Indeed, this is consistent with the anaplerotic 
maintenance of this cycle, to cope with reduced glucose uptake and glycolytic 
conversion found for Quercetin treatment. 
Interestingly, contrarily to Quercetin, Naringenin treatment induced higher 
intracellular levels of glutamate in both M0 and M1 macrophages and of glutamine 
in treated pre-polarized M1 macrophages (Figure 29 d,e). This suggests that 
glutaminolysis was not upregulated in Naringenin-treated macrophages. This 
difference adds up to the distinct TCA cycle modulation found for the two 
flavonoids. 
As for Naringin, it did not cause any significant changes in glutamine 
metabolism. 
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Figure 29: Variations in extracellular glutamine (a-c), intracellular glutamine (d), and 
intracellular glutamate (e) in macrophages incubated under different conditions, relative to 
respective controls (n=6). *p-value < 0.05; **p-value < 0.01. 
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The changes in intracellular levels of other amino acids, found to vary 
significantly with at least one of the stimuli tested, are shown in Figure 30. Again, 
M1 and M2 macrophages were found to respond differently in what concerns amino 
acids composition. In particular, compared to unstimulated macrophages, M1 cells 
showed decreased levels of branched chain amino acids (which did not vary in M2 
macrophages) and of N-acetylaspartate (which significantly increased upon M2 
activation). On the other hand, glycine and alanine were higher in M1 macrophages 
and decreased in M2 cells.  
With Quercetin treatment, the levels of most amino acids assessed 
decreased in both M0 and pre-polarized M1 macrophages. Such variation is 
consistent with the anaplerotic fueling of the TCA cycle.102,201 For example, alanine 
and glycine can be converted into pyruvate, isoleucine into succinyl-CoA or acetyl-
CoA, proline into glutamate and then α-ketoglutarate, asparagine and aspartate to 
oxaloacetate. Interestingly, the variation in aspartate upon Quercetin treatment was 
dependent on macrophage initial activation, increasing in Quercetin-treated M0 
macrophages. This could be associated with the conversion of glutamate and 
oxaloacetate into α-ketoglutarate to fuel the TCA cycle, with aspartate being the 
other product in this metabolic reaction.202 This is consistent with increased 
glutaminolysis caused by Quercetin treatment, as suggested earlier. 
Again, the effects of Naringenin on most amino acids were different to those 
of Quercetin. Moreover, several variations were dependent on macrophage 
activation state. For instance, asparagine decreased in Naringenin-treated M0 
macrophages but increased in pre-polarized M1 macrophages, whereas an 
opposite variation was found for glycine and valine.  
As for Naringin, it only caused mild variations in a few amino acids (Figure 
27). 
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Figure 30: Intracellular variations of some amino acids in macrophages incubated under 
different conditions, relative to respective controls (n=6). *p-value < 0.05; **p-value < 0.01. 
 
%
 V
a
r
 (
v
s
. 
c
o
n
tr
o
l 
c
e
ll
s
)
M
1
 2
4
h
M
2
 4
8
h
M
0
+
Q
u
e
 2
4
h
M
1
 +
 Q
u
e
 2
4
h
M
0
+
N
g
n
 2
4
h
M
1
 +
 N
g
n
 2
4
h
-5 0
0
5 0
1 0 0
N -A c e ty la s p a r ta te
*
* *
* *
* *
%
 V
a
r
 (
v
s
. 
c
o
n
tr
o
l 
c
e
ll
s
)
M
1
 2
4
h
M
2
 4
8
h
M
0
+
Q
u
e
 2
4
h
M
1
 +
 Q
u
e
 2
4
h
M
0
+
N
g
n
 2
4
h
M
1
 +
 N
g
n
 2
4
h
-3 0
0
3 0
6 0
A s p a rta te
* *
%
 V
a
r
 (
v
s
. 
c
o
n
tr
o
l 
c
e
ll
s
)
M
1
 2
4
h
M
2
 4
8
h
M
0
+
Q
u
e
 2
4
h
M
1
 +
 Q
u
e
 2
4
h
M
0
+
N
g
n
 2
4
h
M
1
 +
 N
g
n
 2
4
h
-6 0
-4 0
-2 0
0
2 0
4 0
A la n in e
*
* *
* *
*
%
 V
a
r
 (
v
s
. 
c
o
n
tr
o
l 
c
e
ll
s
)
M
1
 2
4
h
M
2
 4
8
h
M
0
+
Q
u
e
 2
4
h
M
1
 +
 Q
u
e
 2
4
h
M
0
+
N
g
n
 2
4
h
M
1
 +
 N
g
n
 2
4
h
-5 0
0
A s p a ra g in e
* *
* *
*
%
 V
a
r
 (
v
s
. 
c
o
n
tr
o
l 
c
e
ll
s
)
M
1
 2
4
h
M
2
 4
8
h
M
0
+
Q
u
e
 2
4
h
M
1
 +
 Q
u
e
 2
4
h
M
0
+
N
g
n
 2
4
h
M
1
 +
 N
g
n
 2
4
h
-6 0
-4 0
-2 0
0
2 0
4 0
G ly c in e
* * * *
* *
* *
%
 V
a
r
 (
v
s
. 
c
o
n
tr
o
l 
c
e
ll
s
)
M
1
 2
4
h
M
2
 4
8
h
M
0
+
Q
u
e
 2
4
h
M
1
 +
 Q
u
e
 2
4
h
M
0
+
N
g
n
 2
4
h
M
1
 +
 N
g
n
 2
4
h
-6 0
-4 0
-2 0
0
2 0
4 0
P ro lin e
* *
*
* *
%
 V
a
r
 (
v
s
. 
c
o
n
tr
o
l 
c
e
ll
s
)
M
1
 2
4
h
M
2
 4
8
h
M
0
+
Q
u
e
 2
4
h
M
1
 +
 Q
u
e
 2
4
h
M
0
+
N
g
n
 2
4
h
M
1
 +
 N
g
n
 2
4
h
-4 0
-2 0
0
2 0
L e u c in e
* *
*
* * * *
%
 V
a
r
 (
v
s
. 
c
o
n
tr
o
l 
c
e
ll
s
)
M
1
 2
4
h
M
2
 4
8
h
M
0
+
Q
u
e
 2
4
h
M
1
 +
 Q
u
e
 2
4
h
M
0
+
N
g
n
 2
4
h
M
1
 +
 N
g
n
 2
4
h
-4 0
-2 0
0
2 0
Is o le u c in e
* *
* *
* * *
%
 V
a
r
 (
v
s
. 
c
o
n
tr
o
l 
c
e
ll
s
)
M
1
 2
4
h
M
2
 4
8
h
M
0
+
Q
u
e
 2
4
h
M
1
 +
 Q
u
e
 2
4
h
M
0
+
N
g
n
 2
4
h
M
1
 +
 N
g
n
 2
4
h
-2 0
0
2 0
4 0
V a lin e
* *
* *
* *
*
a) b) c) 
f) e) d) 
g) h) i) 
89 
 
 
3.3.4. Effects on glutathione metabolism 
The reduced form of the tripeptide glutathione (GSH, Glu-Cys-Gly) is an 
important scavenger of ROS and its ratio to the oxidized form (GSSG) is regarded 
as a marker of oxidative stress.203 Figure 31 compiles the variations in GSH and 
GSSG found in this work. In M1 and M2 cells, GSH and GSSG levels did not vary 
significantly, and their ratio remained unaltered.  Quercetin treatment, however, 
significantly affected glutathione levels. Compared to respective controls, 
Quercetin-treated M0 macrophages showed lower GSH and higher GSSG (i.e. 
decreased GSH:GSSG ratio), which suggests induction of ROS. Indeed, in 
agreement with inhibited glycolysis and an active TCA cycle, it is possible that 
Quercetin intensified mitochondrial oxidative metabolism and, consequently, ROS 
generation. In this scenario, GSH would be extensively converted to GSSG in order 
to neutralize ROS, an hypothesis which requires further confirmation, e.g. through 
measurement of oxygen consumption and intracellular ROS.  
Interestingly, these changes in Quercetin-treated M0 macrophages were 
also accompanied by a significant increase in methylguanidine (Figure 21), which 
is a product of protein catabolism found to inhibit iNOS and hence the production 
of the pro-inflammatory mediator NO, as well as TNF-α.204 Therefore, this variation 
could represent a countermeasure to cope with reactive species and reflect the 
anti-inflammatory action of Quercetin.  
On the other hand, pre-polarized M1 macrophages showed a different 
response, whereby GSH increased upon Quercetin treatment. Two hypotheses can 
be drawn. One is that after an expected increase in ROS caused by LPS/IFN,205 
Quercetin could be able to decrease ROS levels, as reported in other studies.206,207 
This would imply a lesser use of GSH, thus explaining its increase compared to 
control M1 macrophages. The other possibility is that cells increased de novo GSH 
synthesis, which is consistent with decreased levels of two precursor amino acids 
(glycine and glutamate).203 Again, further assays are required to verify these 
hypotheses.  
Naringenin treatment also induced a decrease in GSH in M0 macrophages, 
which could either mean ROS neutralization (as suggested for Quercetin), or 
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inhibited synthesis, agreeing with the accumulation of precursor amino acids 
glycine and glutamate. 
Regarding the effects of Naringin on glutathione metabolism, the results 
point to GSH conversion to GSSG, probably to neutralize ROS, as suggested for 
the other flavonoids.  
 
Figure 31: Intracellular variations of GSH and GSSG in macrophages incubated under 
different conditions, relative to respective controls (n=6). *p-value < 0.05; **p-value < 0.01. 
 
Figure 32 shows an integrated view of the metabolic changes described 
above. 
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Figure 32: Schematic diagram of main metabolic effects in THP-1 derived macrophages 
incubated under different conditions: LPS+IFN-γ (red arrows), IL-4+IL-13 (purple arrows),  
Quercetin (light green arrows), Quercetin on pre-polarized macrophages (dark green 
arrows), Naringenin (light blue arrows), Naringenin on pre-polarized macrophages (dark 
blue arrows). Naringin effects not included due to their low magnitude/significance. Thick 
arrows indicate  |% variation| > 300%. 
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3.3.5. Other metabolic effects 
 
Interestingly, the three flavonoids tested also affected cells energy reserves. 
In most conditions, ATP decreased and ADP increased, possibly reflecting ATP 
hydrolysis and the release of free energy to perform cellular work. Exceptions 
regarded increases in ATP seen in M0 macrophages treated with Quercetin for 6h 
or with Naringenin for 6/48h. Interestingly, the levels of creatine and 
phosphocreatine also showed large variations. While phosphocreatine is 
recognised as an important energy transducer in muscle, heart and brain 
tissues,208,209 its role on macrophages is less well established. Still, early works 
found that monocyte to macrophage differentiation was accompanied by the 
development of a phosphocreatine pool and that macrophages expressed creatine 
kinase, the enzyme responsible for the interconversion of these metabolites to 
replenish ATP in situations of high metabolic demand.210 In the present study, 
phosphocreatine decreased upon treatment of pre-polarized M1 macrophages with 
each flavonoid. Therefore, it would be interesting to assess if the expression and/or 
activity of creatine kinase are modulated by these compounds.  
Finally, there were also noticeable effects on choline-containing compounds, 
which are associated with the structural components of membranes, namely 
phosphatidylcholines. Choline and phosphocholine increased in all M0 flavonoid-
treated macrophages, while glycerophosphocholine increased in the presence of 
Quercetin but decrease for the other two flavonoids. In pre-polarized M1 
macrophages, the effects on these compounds were more variable.  
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In this thesis, 1H-NMR based metabolomics proved to be a very useful tool for 
characterizing the metabolic profiles of human THP-1 derived macrophages. Near 
50 intracellular metabolites were detected in the cells polar extracts 
(endometabolome), whereas analysis of cells-conditioned culture medium 
(exometabolome) was useful to assess the consumption/excretion of several 
substrates/products. Multivariate analysis and discrete quantitative assessments of 
metabolic profiles revealed consistent variations upon exposure of macrophages 
to different stimuli, namely LPS/IFN-γ (M1 polarization), IL-4/IL-13 (M2 polarization) 
and three flavonoids (Quercetin, Naringenin and Naringin).  
As expected, M1 and M2 polarization states were associated with considerably 
different metabolic profiles. Some of the main differences included changes in TCA 
cycle intermediates. In particular, M1 macrophages showed marked increases in 
succinate, citraconate and itaconate, in agreement with the well documented 
remodeling of this pathway in pro-inflammatory macrophages. On the other hand, 
M2 macrophages appeared to display increased glutaminolysis and showed 
decreased levels of succinate, a metabolite currently viewed as an important pro-
inflammatory mediator. Also, while M2 macrophages showed unaltered 
intracellular ATP and increased UTP levels, ATP/UTP energy reserves decreased 
significantly in M1 macrophages, possibly in association with the predominance of 
oxidative pathways in M2 cells when compared with M1 macrophages. 
Furthermore, other less known differences between M1 and M2 cells were 
revealed, particularly in amino acids (alanine, glycine, N-acetylaspartate) and 
membrane-related metabolites (choline compounds and myo-inositol). Finally, it 
should be noted that M1 and M2 macrophages also shared some common 
features, namely concerning upregulated glucose uptake and glycolysis, and 
variations in antioxidant metabolites.  
The effects of Quercetin, Naringenin and Naringin on macrophage metabolome 
were, to our knowledge, newly reported in this thesis. These compounds have well 
known anti-inflammatory activity, as corroborated by our results on cytokine 
production. Indeed, they attenuated the levels of several pro-inflammatory 
cytokines in the medium supernatants of treated macrophages. Additionally, 
Naringenin treatment caused an increase in the anti-inflammatory cytokine CCL17, 
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suggesting potential pro-resolving activity. At the metabolic level, the three 
flavonoids produced multiple effects, with the strongest impact being observed for 
Quercetin and the mildest for Naringin (Figure 33).  
 
Figure 33: Heatmap of the main metabolite variations in the polar extracts of pre-polarized 
M1 macrophages upon a 24h treatment with: i) Quercetin (60 µM), ii) Naringenin (100 µM) 
and ii) Naringin (200 µM). The color scale represents percentage of variation relative to 
respective controls (M1 + medium) (n=6). *p-value < 0.05; **p-value < 0.01 
 
Quercetin-induced metabolic variations suggested the following main effects: i) 
downregulation of glucose uptake (and possibly glycolysis); ii) downregulation of 
the pro-inflammatory TCA cycle metabolite succinate, accompanied, in flavonoid-
treated M1 pre-polarized macrophages, by increased production of the anti-
inflammatory metabolite itaconate; iii) intensification of anaplerotic reactions 
(including glutaminolysis) to fuel the TCA cycle; iv) accumulation of citrate, possibly 
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due to impairment of fatty acid synthesis; v) alteration of cells redox state, found to 
be highly dependent on macrophage initial polarization state; vi) alteration of 
energy reserves and involvement of the phosphocreatine - creatine kinase system; 
vii) membrane modification. Most of these effects were common to all incubation 
times tested in M0 macrophages (6, 24 and 48h). Still, oscillation in the magnitude 
of changes, together with a few time-dependent alterations (e.g. seen for aspartate, 
a vital amino acid in TCA cycle replenishment, and for the energetic molecules ATP 
and UTP), underscored the dynamic nature of metabolic adaptations.  
In the case of Naringenin, metabolic changes appeared to be greatly dependent 
on both the incubation time and initial macrophage polarization state. Focusing on 
the 24h incubations, the main Naringenin effects were suggested to be: i) 
upregulated/downregulated glucose uptake in Naringenin-treated M0/M1 
macrophages, respectively; ii) TCA cycle modulation involving decreased citrate 
levels (contrarily to Quercetin) and, in M1 macrophages, decreased succinate and 
itaconate levels; iii) very low impact on amino acids in M0 macrophages, and 
changes in M1 macrophages mostly contrary to those found for Quercetin; iv) 
antioxidant response; v) alteration in ATP, UTP and phosphocreatine pools, 
dependent on macrophage initial polarization; vi) membrane modification.  
The impact of Naringin on the cells metabolome was much lower than that 
observed for the other flavonoids. The main effects were suggested to include: i) 
impaired glucose uptake in Naringin-treated M1 pre-polarized macrophages; ii) 
antioxidant response (mainly GSH to GSSG conversion); iii) altered pool of energy-
related metabolites; iv) membrane modification. TCA cycle and amino acids 
metabolism appeared to remain practically unaltered. Given the high hydrophilicity 
of Naringin, it is expectable that this flavonoid is less cell-permeable than the other 
compounds tested. Indeed, in colorectal adenocarcinoma Caco-2 cells, Naringin 
showed much lower permeability than Naringenin, and so did other flavonoid 
glycosides.211 This lower internalization could justify the less pronounced effects 
on the intracellular metabolome. Further studies are warranted to evaluate 
flavonoids uptake.  
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Overall, this work has shown that, although sharing similar ability to attenuate 
anti-inflammatory activity of macrophages, the three flavonoids modulate 
macrophage metabolism in distinct ways, underlying the need for an in depth study 
of their modes of action. This is especially interesting considering that both 
Naringenin and Quercetin have been reported to influence some signaling 
pathways in a similar manner (e.g. activation of AMPK, inhibition of MAPK, 
inhibition of NF-kB).161,212 In the future, it would be important to assess the 
expression and/or activity of key enzymes involved in glycolysis, TCA cycle, 
glutaminolysis and FA synthesis, to verify the hypotheses generated based on the 
metabolomics results. Moreover, measurements of oxygen consumption rate, 
mitochondrial membrane potential and production of reactive oxygen species 
would nicely complement this work and help to further advance current 
understanding on flavonoid-mediated modulation of macrophage metabolism. This 
knowledge is expected to support the development of flavonoids as 
immunomodulatory drugs, especially aimed at attenuating and/or resolving 
inflammation, for instance, in the context of chronic inflammatory diseases or the 
rejection of implantable biomaterials. 
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Figure S1: Multivariate analysis of 1H-NMR spectra from the polar extracts of THP-1 
derived macrophages comparing M0 macrophages (grey) and Quercetin-treated 
macrophages (green) , incubated for: a) 6h, b) 24h and c) 48h. M1 macrophages treated 
with Quercetin for 24h (d). PCA and PLS-DA scores scatter plots (left and center, 
respectively) and LV1 loadings w (right), colored according to variable importance to 
projection (VIP). 
Q2=0.729 
Q2=0.864 
Q2=0.865 
a) 
b) 
c) 
d) 
VIP 
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VIP 
131 
 
 
Figure S2: Multivariate analysis of 1H-NMR spectra from the polar extracts of THP-1 
derived macrophages comparing M0 macrophages (grey) and Naringenin-treated 
macrophages (blue) , incubated for: a) 6h, b) 24h and c) 48h. M1 macrophages treated 
with Naringenin for 24h (d). PCA and PLS-DA scores scatter plots (left and center, 
respectively) and LV1 loadings w (right), colored according to variable importance to 
projection (VIP). 
Q2=0.623 
Q2=0.927 
Q2=0.777 
a) 
b) 
c) 
d) 
VIP 
VIP 
VIP 
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Figure S3: Multivariate analysis of 1H-NMR spectra from the polar extracts of THP-1 
derived macrophages comparing M0 macrophages (grey) and Naringin-treated 
macrophages (pink) , incubated for: a) 6h, b) 24h and c) 48h. M1 macrophages treated 
with Naringin for 24h (d). PCA and PLS-DA scores scatter plots (left and center, 
respectively) and LV1 loadings w (right), colored according to variable importance to 
projection (VIP). 
a) 
b) 
c) 
d) 
Q2=0.577 
Q2=0.636 
Q2=0.601 
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Table S1: Assignment of resonances in the 1H-NMR profile of polar extracts from THP-
1 derived macrophages. Multiplicity: s, singlet; d, doublet; t, triplet; q, quartet; m, 
multiplet; dd, doublet of doublets; dt, doublet of triplets; td, triplet of doublets. 
 
No. Compound δ 1H in ppm (multiplicity, assignment) 
1 Acetate 1.926 (s, β-CH3) 
2 Acetone 2.236 (s, CH3) 
3 ADP 
4.235 (m, C5’H, ribose); 4.40 (m, C4’H, ribose);  
4.60 (m, C2’H, ribose); 6.155 (d, C1’H, ribose);  
8.285 (s, C8H, ring); 8.53 (s, C2H, ring) 
4 Alanine 1.487 (d, β-CH2); 3.781 (q, α-CH) 
5 Arginine 
1.659 (m, γ-CH2); 1.92 (m, β-CH2); 
3.254 (t, δ-CH2); 3.784 (t, α-CH) 
6 Asparagine 
2.881 (m, β-CH); 2.931 (m, β’-CH);  
4.012 (dd, α-CH) 
7 Aspartate 
2.672 (dd, β-CH); 2.802 (dd, β’-CH);  
3.903 (dd, α-CH) 
8 ATP 
4.222 (m, C5’H, ribose); 4.296 (m. C5’’H, ribose); 
4.41 (m, C4’H, ribose); 4.61 (m, C2’H, ribose); 
6.155 (d, C1’H, ribose); 8.825 (s, C8H, ring); 
8.534 (s, C2H, ring) 
9 Choline 
3.214 (s, N(CH3)3); 3.523 (m, CH2 (NH)); 
4.067 (m, CH2(OH)) 
10 Citraconate 1.938 (d, C7H); 5.513 (d, C2H) 
11 Citrate 2.536 (d, α-CH2 / β-CH2); 2.662 (d, α’-CH2 / β’-CH2) 
12 Creatine 3.039 (s, CH3); 3.939 (s, N-CH3) 
13 Formate 8.465 (s, CH) 
14 Fumarate 6.526 (s, CH) 
15 Glucose 
3.239 (dd, C3H); 3.405 (m, C5H); 3.464 (m, C6H); 
3.535 (dd, C3H); 3.72 (m, C4H, C11H);  
3.827 (m, C6H, C11H); 3.895 (dd, C11H); 
4.658 (d, C2H); 5.235 (d, C2H) 
16 Glutamate 
2.044 (m, β-CH); 2.12 (β’-CH); 
2.333 (m, γ-CH2); 3.77 (dd, α-CH) 
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Table S1 (cont.): Assignment of resonances in the 1H-NMR profile of polar extracts from 
THP-1 derived macrophages. Multiplicity: s, singlet; d, doublet; t, triplet; q, quartet; m, 
multiplet; dd, doublet of doublets; dt, doublet of triplets; td, triplet of doublets. 
 
No. Compound δ 1H in ppm (multiplicity, assignment) 
17 Glutamine 2.142 (m, β-CH2); 2.454 (m, γ-CH2); 3.78 (t, α-CH) 
18 Glycine 3.575 (s, α-CH2) 
19 
Glutathione, oxidized 
(GSSG) 
2.17 (m, β-CH2, Glu); 2.535 (m, γ-CH2, Glu);  
2.988 (m, β-CH2, Cys); 3.314 (m, β-CH2, Cys’); 
3.783 (m, α-CH2, Gly); 3.783 (m, α-CH, Glu) 
20 
Glutathione, reduced  
(GSH) 
2.175 (m, β-CH2, Glu); 2.564 (m, γ-CH2, Glu); 
2.96 (m, β-CH2, Cys); 3.783 (m, α-CH, Gly); 
4.603 (q, α-CH, Cys) 
21 Glycerophosphocholine 
3.24 (s, N(CH3)3); 3.675 (m, β’-CH2(N) / γ-CH2(OH)); 
3.917 (s, α-CH2 / β-CH2); 4.326 (m, α’-CH2(P)) 
22 Histidine 
3.232 (m, β-CH2); 4.00 (m, α-CH2);  
7.165 (s, C4H, ring); 8.072 (s, C2H, ring) 
23 Isoleucine 
0.944 (t, δ-CH3); 1.013 (d, β-CH3);  
1.258 (m, γ-CH2); 1.470 (m, γ’-CH2); 
1.984 (m, β-CH); 3.673 (d, α-CH) 
24 Itaconate 3.158 (m, α-CH2), 5.382 (m, CH2); 5.860 (m, CH2’) 
25 Lactate 1.329 (d, β-CH3); 4.125 (q, α-CH) 
26 Leucine 
0.963 (t, δ-CH3); 1.699 (m, γ-CH / β-CH2); 
3.736 (m, α-CH) 
27 Lysine 
1.439 (m, γ-CH2); 1.725 (m, δ-CH2);  
1.904 (m, β-CH2); 3.001 (t, ε-CH2); 
3.765 (t, α-CH) 
28 Methylguanidine 2.845 (s, CH3(N)) 
29 myo-Inositol 
3.286 (t, C5H); 3.544 (dd, C1’H / C3H); 
3.632 (t, C4H / C6H); 4.072 (t, C2H) 
30 NAD+ 
4.230 (m, A5’H); 4.357 (m, A4’H);  
4.383 (m, A4’H / N5’H); 4.411 (dd, N3’H); 
4.469 (m, A3’H); 4.513 (m, N2’H); 6.031 (d, N1’H); 
6.104 (d, A1’H); 8.172 (s, A2H / N5H); 
8.827 (d, N4H); 9.122 (d, N6H); 9.339 (s, N2H)  
31 N-Acetylaspartate 
2.030 (s, CH3); 2.507 (dd, β-CH2);  
2.69 (dd, β’-CH2); 4.398 (dd, α-CH) 
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Table S1 (cont.): Assignment of resonances in the 1H-NMR profile of polar extracts from 
THP-1 derived macrophages. Multiplicity: s, singlet; d, doublet; t, triplet; q, quartet; m, 
multiplet; dd, doublet of doublets; dt, doublet of triplets; td, triplet of doublets. 
No. Compound δ 1H in ppm (multiplicity, assignment) 
32 Pantothenate 
0.905 (s, CH3); 0.925 (s,CH3); 2.435 (t, α-CH2); 
3.416 (d, CH2); 3.438 (q, β-CH2); 3.510 (d, CH2); 
3.99 (s, CH) 
33 Phenylalanine 
3.146 (m, β-CH); 3.280 (dd, β’-CH); 4.00 (m, α-CH); 
7.384 (d, C2H / C6H, ring); 7.39 (d, C4H, ring); 
7.43 (t, C3H / C5H, ring) 
34 Phosphocholine 
3.23 (s, N(CH3)3); 3.62 (m, N-CH2); 
4.172 (m, PO3-CH2) 
35 Phosphocreatine 3.04 (s, CH3); 3.955 (s, CH2) 
36 Phosphoethanolamine 3.232 (t, CH2(O)); 4.005 (td, N-CH2) 
37 Proline 
2.014 (m, γ-CH2); 2.08 (m, β-CH); 2.35 (m, β’-CH); 
3.35 (dt, δ-CH); 3.418 (dt-δ’-CH); 4.137 (dd, α-CH) 
38 Pyroglutamate 
2.05 (m, β-CH2); 2.40 (m, γ-CH2); 2.495 (m, β’-CH2); 
4.17 (dd, α-CH) 
39 Serine 3.852 (dd, α-CH); 3.99 (m, β-CH2) 
40 Succinate 2.41 (s, CH2) 
41 Taurine 3.27 (t, S-CH2); 3.43 (t, N-CH2) 
42 Threonine 1.341 (d, γ-CH3); 3.950 (d, α-CH); 4.269 (m, β-CH) 
43 Tyrosine 
3.07 (m, β’-CH); 3.21 (m, β-CH);  
3.95 (m, α-CH); 6.91 (d, C3H / C5H, ring); 
7.21 (d, C2H / C6H, ring) 
44 UDP 
4.231 (m, C5’H, ribose); 4.280 (m, C4’H, ribose); 
4.398 (t, C2’H, ribose); 4.44 (t, C3’H, ribose); 
5.97 (s, C1’H, ribose); 5.98 (d, C6H, ring); 
7.995 (d, C5H, ring)  
45 UTP 
4.26 (m, C5’H, ribose); 4.295 (m, C4’H, ribose); 
4.416 (t, C2’H, ribose); 4.45 (t, C3’H, ribose); 
5.98 (s, C1’H, ribose); 5.995 (d, C6H, ring); 
7.982 (d, C5H, ring)  
46 Valine 1.027 (d, γ-CH2); 2.265 (m, β-CH); 3.625 (d, α-CH) 
 
